{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:36:50Z","timestamp":1792427810182,"version":"4.5.0"},"reference-count":270,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00537"],"award-info":[{"award-number":["2021 SGR 00537"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2024-LLAV-00042"],"award-info":[{"award-number":["2024-LLAV-00042"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["ICREA Acad\u00e8mia 2024"],"award-info":[{"award-number":["ICREA Acad\u00e8mia 2024"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["202207-31"],"award-info":[{"award-number":["202207-31"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-118699GB-100"],"award-info":[{"award-number":["PID2020-118699GB-100"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["Not specified"],"award-info":[{"award-number":["Not specified"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006531","name":"Departament d'Universitats, Recerca i Societat de la Informaci\u00f3","doi-asserted-by":"publisher","award":["FISDUR-2024"],"award-info":[{"award-number":["FISDUR-2024"]}],"id":[{"id":"10.13039\/501100006531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s13346-025-01887-9","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:05:52Z","timestamp":1749909952000},"page":"797-824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Crossing the blood\u2013brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Elena","family":"Haro-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Muscolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-3213","authenticated-orcid":false,"given":"Cristina","family":"Fornaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"3","key":"1887_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med. 2010;14(3):457\u201387. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01010.x.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1887_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41398-024-02898-9","volume":"14","author":"NS Ogonowski","year":"2024","unstructured":"Ogonowski NS, Garc\u00eda-Mar\u00edn LM, Fernando AS, Flores-Ocampo V, Renter\u00eda ME. Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure. Transl Psychiatry. 2024;14(1):185. https:\/\/doi.org\/10.1038\/s41398-024-02898-9.","journal-title":"Transl Psychiatry"},{"issue":"11","key":"1887_CR3","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1093\/brain\/awad242","volume":"146","author":"KL Elvidge","year":"2023","unstructured":"Elvidge KL, et al. The collective burden of childhood dementia: a scoping review. Brain. 2023;146(11):4446\u201355. https:\/\/doi.org\/10.1093\/brain\/awad242.","journal-title":"Brain"},{"key":"1887_CR4","doi-asserted-by":"publisher","unstructured":"Wang S, Jiang Y, Yang A, Meng F, Zhang J. The expanding burden of neurodegenerative diseases: an unmet medical and social need. Aging Dis. 2024;0. https:\/\/doi.org\/10.14336\/AD.2024.1071.","DOI":"10.14336\/AD.2024.1071"},{"key":"1887_CR5","doi-asserted-by":"publisher","first-page":"122899","DOI":"10.1016\/j.lfs.2024.122899","volume":"352","author":"AN Al-Thani","year":"2024","unstructured":"Al-Thani AN, Jan AG, Abbas M, Geetha M, Sadasivuni KK. Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review. Life Sci. 2024;352:122899. https:\/\/doi.org\/10.1016\/j.lfs.2024.122899.","journal-title":"Life Sci"},{"issue":"1","key":"1887_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","volume":"20","author":"N Joudeh","year":"2022","unstructured":"Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnology. 2022;20(1):262. https:\/\/doi.org\/10.1186\/s12951-022-01477-8.","journal-title":"J Nanobiotechnology"},{"key":"1887_CR7","doi-asserted-by":"publisher","first-page":"102640","DOI":"10.1016\/J.CIS.2022.102640","volume":"303","author":"A Selmani","year":"2022","unstructured":"Selmani A, Kova\u010devi\u0107 D, Bohinc K. Nanoparticles: From synthesis to applications and beyond. Adv Colloid Interface Sci. 2022;303:102640. https:\/\/doi.org\/10.1016\/J.CIS.2022.102640.","journal-title":"Adv Colloid Interface Sci"},{"issue":"3","key":"1887_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nano12030457","volume":"12","author":"V Harish","year":"2022","unstructured":"Harish V, et al. Review on nanoparticles and nanostructured materials: bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial, and agro-food applications. Nanomaterials. 2022;12(3):457. https:\/\/doi.org\/10.3390\/nano12030457.","journal-title":"Nanomaterials"},{"issue":"1","key":"1887_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2045-8118-9-23","volume":"9","author":"A-C Luissint","year":"2012","unstructured":"Luissint A-C, Artus C, Glacial F, Ganeshamoorthy K, Couraud P-O. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS. 2012;9(1):23. https:\/\/doi.org\/10.1186\/2045-8118-9-23.","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"1887_CR10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s11095-024-03790-3","volume":"41","author":"H Zeng","year":"2024","unstructured":"Zeng H, Lu H, Yang J, Hu P. An update on recent drug delivery systems targeting brain diseases via the transnasal pathway. Pharm Res. 2024;41(11):2121\u201341. https:\/\/doi.org\/10.1007\/s11095-024-03790-3.","journal-title":"Pharm Res"},{"issue":"1","key":"1887_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther. 2023;8(1):217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1887_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/svn-2018-000198","volume":"4","author":"L Xu","year":"2019","unstructured":"Xu L, Nirwane A, Yao Y. Basement membrane and blood\u2013brain barrier. Stroke Vasc Neurol. 2019;4(2):78\u201382. https:\/\/doi.org\/10.1136\/svn-2018-000198.","journal-title":"Stroke Vasc Neurol"},{"key":"1887_CR13","doi-asserted-by":"publisher","unstructured":"Brown LS, Foster CG, Courtney J-M, King NE, Howells DW, Sutherland BA. Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci. 2019;13. https:\/\/doi.org\/10.3389\/fncel.2019.00282.","DOI":"10.3389\/fncel.2019.00282"},{"issue":"1","key":"1887_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018;13(1):57. https:\/\/doi.org\/10.1186\/s13024-018-0286-0.","journal-title":"Mol Neurodegener"},{"key":"1887_CR15","doi-asserted-by":"publisher","unstructured":"Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC. The blood-brain barrier: an engineering perspective. Front Neuroeng. 2013;6. https:\/\/doi.org\/10.3389\/fneng.2013.00007.","DOI":"10.3389\/fneng.2013.00007"},{"key":"1887_CR16","doi-asserted-by":"publisher","first-page":"119582","DOI":"10.1016\/j.ijpharm.2020.119582","volume":"586","author":"M Azarmi","year":"2020","unstructured":"Azarmi M, Maleki H, Nikkam N, Malekinejad H. Transcellular brain drug delivery: A review on recent advancements. Int J Pharm. 2020;586:119582. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119582.","journal-title":"Int J Pharm"},{"issue":"1","key":"1887_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3.","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"1887_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ajps.2019.09.002","volume":"15","author":"C Hu","year":"2020","unstructured":"Hu C, Tao L, Cao X, Chen L. The solute carrier transporters and the brain: Physiological and pharmacological implications. Asian J Pharm Sci. 2020;15(2):131\u201344. https:\/\/doi.org\/10.1016\/j.ajps.2019.09.002.","journal-title":"Asian J Pharm Sci"},{"issue":"10","key":"1887_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2174\/13816128113199990463","volume":"20","author":"L Sanchez-Covarrubias","year":"2014","unstructured":"Sanchez-Covarrubias L, Slosky L, Thompson B, Davis T, Ronaldson P. Transporters at CNS barrier sites: obstacles or opportunities for drug d elivery? Curr Pharm Des. 2014;20(10):1422\u201349. https:\/\/doi.org\/10.2174\/13816128113199990463.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"1887_CR20","doi-asserted-by":"publisher","first-page":"e0252341","DOI":"10.1371\/journal.pone.0252341","volume":"16","author":"C McQuaid","year":"2021","unstructured":"McQuaid C, Halsey A, Dubois M, Romero I, Male D. Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers. PLoS One. 2021;16(6):e0252341. https:\/\/doi.org\/10.1371\/journal.pone.0252341.","journal-title":"PLoS One"},{"key":"1887_CR21","doi-asserted-by":"publisher","unstructured":"Hartl N et al. ApoE - functionalization of nanoparticles for targeted brain delivery - a feasible method for polyplexes?. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-3265897\/v1.","DOI":"10.21203\/rs.3.rs-3265897\/v1"},{"issue":"6","key":"1887_CR22","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27(6):2659\u201373. https:\/\/doi.org\/10.1038\/s41380-022-01511-z.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1887_CR23","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/mp300495e","volume":"10","author":"DJ Wolak","year":"2013","unstructured":"Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm. 2013;10(5):1492\u2013504. https:\/\/doi.org\/10.1021\/mp300495e.","journal-title":"Mol Pharm"},{"key":"1887_CR24","doi-asserted-by":"publisher","unstructured":"Yang NJ, Hinner MJ. Getting across the cell membrane: an overview for small molecules, peptides, and proteins. 2015;29\u201353. https:\/\/doi.org\/10.1007\/978-1-4939-2272-7_3.","DOI":"10.1007\/978-1-4939-2272-7_3"},{"issue":"6","key":"1887_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.9734\/BJMMR\/2015\/15493","volume":"6","author":"M Fakhoury","year":"2015","unstructured":"Fakhoury M, Takechi R, Al-Salami H. Drug permeation across the blood-brain barrier: applications of nanotechnology. Br J Med Med Res. 2015;6(6):547\u201356. https:\/\/doi.org\/10.9734\/BJMMR\/2015\/15493.","journal-title":"Br J Med Med Res"},{"issue":"8","key":"1887_CR26","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.3390\/ijms23084153","volume":"23","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Alomari S, Tyler BM. Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology. Int J Mol Sci. 2022;23(8):4153. https:\/\/doi.org\/10.3390\/ijms23084153.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1887_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/nano.2006.1.2.115","volume":"1","author":"TJ Webster","year":"2006","unstructured":"Webster TJ. Nanomedicine: what\u2019s in a definition? Int J Nanomedicine. 2006;1(2):115\u20136. https:\/\/doi.org\/10.2147\/nano.2006.1.2.115.","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"1887_CR28","doi-asserted-by":"publisher","first-page":"13257","DOI":"10.1021\/acsnano.2c08675","volume":"16","author":"LM Liz-Marz\u00e1n","year":"2022","unstructured":"Liz-Marz\u00e1n LM, et al. What do we mean when we say nanomedicine? ACS Nano. 2022;16(9):13257\u20139. https:\/\/doi.org\/10.1021\/acsnano.2c08675.","journal-title":"ACS Nano"},{"issue":"4","key":"1887_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","volume":"14","author":"SZ Alshawwa","year":"2022","unstructured":"Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. 2022;14(4):883. https:\/\/doi.org\/10.3390\/pharmaceutics14040883.","journal-title":"Pharmaceutics"},{"key":"1887_CR30","unstructured":"Nalwa HS. The encyclopedia of nanoscience and nanotechnology, vol. 30. [Internet] American Scientific Publishers. 2019. [accessed 08 May 2025] 1-58883-2120."},{"issue":"5","key":"1887_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1021\/acschemneuro.9b00691","volume":"11","author":"H Mohamadpour","year":"2020","unstructured":"Mohamadpour H, Azadi A, Rostamizadeh K, Andalib S, Saghatchi Zanjani MR, Hamidi M. Preparation, optimization, and evaluation of Methoxy Poly(ethylene glycol)- co -Poly(\u03b5-caprolactone) nanoparticles loaded by Rivastigmine for brain delivery. ACS Chem Neurosci. 2020;11(5):783\u201395. https:\/\/doi.org\/10.1021\/acschemneuro.9b00691.","journal-title":"ACS Chem Neurosci"},{"issue":"43","key":"1887_CR32","doi-asserted-by":"publisher","first-page":"12913","DOI":"10.1039\/D2SC03298H","volume":"13","author":"Q Hou","year":"2022","unstructured":"Hou Q, et al. Dual targeting nanoparticles for epilepsy therapy. Chem Sci. 2022;13(43):12913\u201320. https:\/\/doi.org\/10.1039\/D2SC03298H.","journal-title":"Chem Sci"},{"key":"1887_CR33","doi-asserted-by":"publisher","unstructured":"Medina DX, Chung EP, Teague CD, Bowser R, Sirianni RW. Intravenously administered, retinoid activating nanoparticles increase lifespan and reduce neurodegeneration in the SOD1G93A mouse model of ALS. Front Bioeng Biotechnol. 2020;8. https:\/\/doi.org\/10.3389\/fbioe.2020.00224.","DOI":"10.3389\/fbioe.2020.00224"},{"issue":"5","key":"1887_CR34","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1021\/acsbiomaterials.9b01820","volume":"6","author":"A Ambrosone","year":"2020","unstructured":"Ambrosone A, De Matteis L, Serrano-Sevilla I, Tortiglione C, De La Fuente JM. Glycogen synthase kinase 3\u03b2 inhibitor delivered by chitosan nanocapsules promotes safe, fast, and efficient activation of Wnt signaling In Vivo. ACS Biomater Sci Eng. 2020;6(5):2893\u2013903. https:\/\/doi.org\/10.1021\/acsbiomaterials.9b01820.","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"1887_CR35","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s10904-023-02690-0","volume":"33","author":"M Sankar","year":"2023","unstructured":"Sankar M, Karthikeyan R, Vigneshkumar S. synthesis and characterization of chitosan acetylcholine nanoparticles for neural disorders associated with cancer treatment. J Inorg Organomet Polym Mater. 2023;33(8):2465\u201384. https:\/\/doi.org\/10.1007\/s10904-023-02690-0.","journal-title":"J Inorg Organomet Polym Mater"},{"key":"1887_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2015.12.029","volume":"223","author":"LJ Cruz","year":"2016","unstructured":"Cruz LJ, et al. Effect of PLGA NP size on efficiency to target traumatic brain injury. J Control Release. 2016;223:31\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.029.","journal-title":"J Control Release"},{"key":"1887_CR37","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.2147\/IJN.S164500","volume":"13","author":"W Pei","year":"2018","unstructured":"Pei W, et al. Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules. Int J Nanomedicine. 2018;13:3731\u201350. https:\/\/doi.org\/10.2147\/IJN.S164500.","journal-title":"Int J Nanomedicine"},{"key":"1887_CR38","doi-asserted-by":"publisher","unstructured":"Huang Q et al. Pathological BBB crossing melanin-like nanoparticles as metal-Ion chelators and neuroinflammation regulators against Alzheimer\u2019s disease. Research. 2023;6. https:\/\/doi.org\/10.34133\/research.0180.","DOI":"10.34133\/research.0180"},{"key":"1887_CR39","doi-asserted-by":"publisher","unstructured":"Kushawaha SK, Ashawat MS, Soni D, Kumar P, Rimpi, Baldi A. Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer\u2019s disease. Brain Res. 2024;1834:148906. https:\/\/doi.org\/10.1016\/j.brainres.2024.148906.","DOI":"10.1016\/j.brainres.2024.148906"},{"key":"1887_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejpb.2023.01.006","volume":"184","author":"M Samir","year":"2023","unstructured":"Samir M, Abdelkader RM, Boushehri MS, Mansour S, Lamprecht A, Tammam SN. Enhancement of mitochondrial function using NO releasing nanoparticles; a potential approach for therapy of Alzheimer\u2019s disease. Eur J Pharm Biopharm. 2023;184:16\u201324. https:\/\/doi.org\/10.1016\/j.ejpb.2023.01.006.","journal-title":"Eur J Pharm Biopharm"},{"key":"1887_CR41","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.2147\/IJN.S140734","volume":"12","author":"F Nouri","year":"2017","unstructured":"Nouri F, Sadeghpour H, Heidari R, Dehshahri A. Preparation, characterization, and transfection efficiency of low molecular weight polyethylenimine-based nanoparticles for delivery of the plasmid encoding CD200 gene. Int J Nanomedicine. 2017;12:5557\u201369. https:\/\/doi.org\/10.2147\/IJN.S140734.","journal-title":"Int J Nanomedicine"},{"issue":"34","key":"1887_CR42","doi-asserted-by":"publisher","first-page":"9764","DOI":"10.1021\/acs.jafc.1c00569","volume":"69","author":"M Yang","year":"2021","unstructured":"Yang M, et al. PLGA-PEG nanoparticles facilitate in vivo anti-Alzheimer\u2019s effects of Fucoxanthin, a marine carotenoid derived from edible brown algae. J Agric Food Chem. 2021;69(34):9764\u201377. https:\/\/doi.org\/10.1021\/acs.jafc.1c00569.","journal-title":"J Agric Food Chem"},{"key":"1887_CR43","doi-asserted-by":"publisher","first-page":"120714","DOI":"10.1016\/j.carbpol.2023.120714","volume":"310","author":"L Yang","year":"2023","unstructured":"Yang L, Wang Y, Li Z, Wu X, Mei J, Zheng G. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease. Carbohydr Polym. 2023;310:120714. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120714.","journal-title":"Carbohydr Polym"},{"key":"1887_CR44","doi-asserted-by":"publisher","unstructured":"Zhang W et al. Trojan horse delivery of 4,4\u2032\u2010Dimethoxychalcone for Parkinsonian neuroprotection. Adv Sci. 2021;8(9). https:\/\/doi.org\/10.1002\/advs.202004555.","DOI":"10.1002\/advs.202004555"},{"key":"1887_CR45","doi-asserted-by":"publisher","unstructured":"Saleem S, Banerjee R, Rajesh Kannan R. Chrysin-loaded chitosan nanoparticle-mediated neuroprotection in A\u03b2 1\u201342 -induced neurodegenerative conditions in Zebrafish. ACS Chem Neurosci. 2022;13(13):2017\u20132034. https:\/\/doi.org\/10.1021\/acschemneuro.2c00240.","DOI":"10.1021\/acschemneuro.2c00240"},{"issue":"10","key":"1887_CR46","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4155\/tde-2018-0033","volume":"9","author":"JC Mamo","year":"2018","unstructured":"Mamo JC, et al. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Ther Deliv. 2018;9(10):703\u20139. https:\/\/doi.org\/10.4155\/tde-2018-0033.","journal-title":"Ther Deliv"},{"issue":"19","key":"1887_CR47","doi-asserted-by":"publisher","first-page":"21822","DOI":"10.1021\/acsami.2c00007","volume":"14","author":"C Ye","year":"2022","unstructured":"Ye C, et al. Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer\u2019s Disease. ACS Appl Mater Interfaces. 2022;14(19):21822\u201335. https:\/\/doi.org\/10.1021\/acsami.2c00007.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1887_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nano.2019.02.004","volume":"17","author":"SG Jeon","year":"2019","unstructured":"Jeon SG, et al. Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer\u2019s disease-related pathology in 5XFAD mice. Nanomedicine. 2019;17:297\u2013307. https:\/\/doi.org\/10.1016\/j.nano.2019.02.004.","journal-title":"Nanomedicine"},{"issue":"10","key":"1887_CR49","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.1021\/acsnano.0c09553","volume":"15","author":"B Surnar","year":"2021","unstructured":"Surnar B, et al. Brain-accumulating nanoparticles for assisting astrocytes to reduce human immunodeficiency virus and drug abuse-induced neuroinflammation and oxidative stress. ACS Nano. 2021;15(10):15741\u201353. https:\/\/doi.org\/10.1021\/acsnano.0c09553.","journal-title":"ACS Nano"},{"key":"1887_CR50","doi-asserted-by":"publisher","unstructured":"Surnar B et al. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection. Proc Nat Acad Sci. 2018;115(52). https:\/\/doi.org\/10.1073\/pnas.1816429115.","DOI":"10.1073\/pnas.1816429115"},{"issue":"3","key":"1887_CR51","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.nano.2016.12.003","volume":"13","author":"E S\u00e1nchez-L\u00f3pez","year":"2017","unstructured":"S\u00e1nchez-L\u00f3pez E, et al. New potential strategies for Alzheimer\u2019s disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe\/PS1dE9. Nanomedicine. 2017;13(3):1171\u201382. https:\/\/doi.org\/10.1016\/j.nano.2016.12.003.","journal-title":"Nanomedicine"},{"issue":"4","key":"1887_CR52","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","volume":"18","author":"T Lei","year":"2024","unstructured":"Lei T, et al. Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer\u2019s disease therapy. ACS Nano. 2024;18(4):3234\u201350. https:\/\/doi.org\/10.1021\/acsnano.3c09715.","journal-title":"ACS Nano"},{"key":"1887_CR53","doi-asserted-by":"publisher","first-page":"124218","DOI":"10.1016\/j.ijpharm.2024.124218","volume":"658","author":"SR Saleh","year":"2024","unstructured":"Saleh SR, et al. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer\u2019s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis. Int J Pharm. 2024;658:124218. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124218.","journal-title":"Int J Pharm"},{"key":"1887_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","volume":"301","author":"A Cano","year":"2019","unstructured":"Cano A, et al. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)\/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer\u2019s disease mice model. J Control Release. 2019;301:62\u201375. https:\/\/doi.org\/10.1016\/j.jconrel.2019.03.010.","journal-title":"J Control Release"},{"issue":"8","key":"1887_CR55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/psc.2640","volume":"20","author":"AS Joshi","year":"2014","unstructured":"Joshi AS, Thakur AK. Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: a step toward therapeutic development in Huntington\u2019s disease. J Pept Sci. 2014;20(8):630\u20139. https:\/\/doi.org\/10.1002\/psc.2640.","journal-title":"J Pept Sci"},{"issue":"1","key":"1887_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1208\/s12248-017-0176-3","volume":"20","author":"D Manickavasagam","year":"2018","unstructured":"Manickavasagam D, Novak K, Oyewumi MO. Therapeutic delivery of simvastatin loaded in PLA-PEG polymersomes resulted in amplification of anti-inflammatory effects in activated microglia. AAPS J. 2018;20(1):18. https:\/\/doi.org\/10.1208\/s12248-017-0176-3.","journal-title":"AAPS J"},{"key":"1887_CR57","doi-asserted-by":"publisher","first-page":"143152","DOI":"10.1016\/j.cej.2023.143152","volume":"466","author":"H Li","year":"2023","unstructured":"Li H, et al. Engineering brain-derived neurotrophic factor mRNA delivery for the treatment of Alzheimer\u2019s disease. Chem Eng J. 2023;466:143152. https:\/\/doi.org\/10.1016\/j.cej.2023.143152.","journal-title":"Chem Eng J"},{"issue":"2","key":"1887_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/1061186X.2017.1354002","volume":"26","author":"R Aalinkeel","year":"2018","unstructured":"Aalinkeel R, et al. Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer\u2019s disease? J Drug Target. 2018;26(2):182\u201393. https:\/\/doi.org\/10.1080\/1061186X.2017.1354002.","journal-title":"J Drug Target"},{"issue":"6","key":"1887_CR59","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1039\/D0NR06249A","volume":"13","author":"Y Mo","year":"2021","unstructured":"Mo Y, et al. Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage. Nanoscale. 2021;13(6):3827\u201340. https:\/\/doi.org\/10.1039\/D0NR06249A.","journal-title":"Nanoscale"},{"issue":"1","key":"1887_CR60","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12951-021-01067-0","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke. J Nanobiotechnol. 2021;19(1):331. https:\/\/doi.org\/10.1186\/s12951-021-01067-0.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"1887_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000519534","volume":"81","author":"M Amini","year":"2022","unstructured":"Amini M, Abdolmaleki Z. The effect of cannabidiol coated by nano-chitosan on learning and memory, hippocampal CB1 and CB2 levels, and amyloid plaques in an Alzheimer\u2019s disease rat model. Neuropsychobiology. 2022;81(3):171\u201383. https:\/\/doi.org\/10.1159\/000519534.","journal-title":"Neuropsychobiology"},{"key":"1887_CR62","doi-asserted-by":"publisher","unstructured":"Zhang X et al. Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.957433.","DOI":"10.3389\/fphar.2022.957433"},{"issue":"3","key":"1887_CR63","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1166\/jbn.2022.3284","volume":"18","author":"Z Li","year":"2022","unstructured":"Li Z, Xu C, Wang Y. Poly d, l-(lactic-co-glycolic) acid PEGylated isoliquiritigenin alleviates traumatic brain injury by reversing cyclooxygenase 2 level. J Biomed Nanotechnol. 2022;18(3):909\u201316. https:\/\/doi.org\/10.1166\/jbn.2022.3284.","journal-title":"J Biomed Nanotechnol"},{"issue":"21","key":"1887_CR64","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1021\/acschemneuro.4c00392","volume":"15","author":"AK Mahanta","year":"2024","unstructured":"Mahanta AK, Chaulagain B, Trivedi R, Singh J. Mannose-functionalized chitosan-coated PLGA nanoparticles for brain-targeted codelivery of CBD and BDNF for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci. 2024;15(21):4021\u201332. https:\/\/doi.org\/10.1021\/acschemneuro.4c00392.","journal-title":"ACS Chem Neurosci"},{"key":"1887_CR65","doi-asserted-by":"publisher","unstructured":"Mohammadbaghban E, Taravati A, Najafzadehvarzi H, Khaleghzadeh\u2010Ahangar H, Tohidi F. Oral administration of encapsulated catechin in chitosan\u2010alginate nanoparticles improves cognitive function and neurodegeneration in an aluminum chloride\u2010induced rat model of Alzheimer\u2019s disease. Physiol Rep. 2024;12(13). https:\/\/doi.org\/10.14814\/phy2.16095.","DOI":"10.14814\/phy2.16095"},{"key":"1887_CR66","doi-asserted-by":"publisher","first-page":"122575","DOI":"10.1016\/j.carbpol.2024.122575","volume":"346","author":"L Biswal","year":"2024","unstructured":"Biswal L, Sahu VK, Sardoiwala MN, Karmakar S, Choudhury SR. Antibody conjugated targeted nanotherapy epigenetically inhibits calpain-mediated mitochondrial dysfunction to attenuate Parkinson\u2019s disease. Carbohydr Polym. 2024;346:122575. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122575.","journal-title":"Carbohydr Polym"},{"issue":"17","key":"1887_CR67","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1039\/D2NR07256D","volume":"15","author":"L Garcia","year":"2023","unstructured":"Garcia L, et al. Ferulic acid-loaded polymeric nanoparticles prepared from nano-emulsion templates facilitate internalisation across the blood\u2013brain barrier in model membranes. Nanoscale. 2023;15(17):7929\u201344. https:\/\/doi.org\/10.1039\/D2NR07256D.","journal-title":"Nanoscale"},{"issue":"13","key":"1887_CR68","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.7150\/thno.19979","volume":"7","author":"C Zhang","year":"2017","unstructured":"Zhang C, et al. Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles. Theranostics. 2017;7(13):3260\u201375. https:\/\/doi.org\/10.7150\/thno.19979.","journal-title":"Theranostics"},{"key":"1887_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","volume":"80","author":"Y Liu","year":"2016","unstructured":"Liu Y, et al. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer\u2019s disease mice. Biomaterials. 2016;80:33\u201345. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.060.","journal-title":"Biomaterials"},{"key":"1887_CR70","doi-asserted-by":"publisher","unstructured":"Gothwal A, Nakhate KT, Alexander A, Ajazuddin, Gupta U. Boosted memory and improved brain bioavailability of rivastigmine: targeting effort to the brain using covalently tethered lower generation PAMAM dendrimers with lactoferrin. Mol Pharm. 2018;15(10):4538\u20134549. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00537.","DOI":"10.1021\/acs.molpharmaceut.8b00537"},{"key":"1887_CR71","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jcis.2016.07.047","volume":"482","author":"HK Patel","year":"2016","unstructured":"Patel HK, Gajbhiye V, Kesharwani P, Jain NK. Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment. J Colloid Interface Sci. 2016;482:142\u201350. https:\/\/doi.org\/10.1016\/j.jcis.2016.07.047.","journal-title":"J Colloid Interface Sci"},{"key":"1887_CR72","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2015.09.003","volume":"217","author":"S Somani","year":"2015","unstructured":"Somani S, Robb G, Pickard BS, Duf\u00e8s C. Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex. J Control Release. 2015;217:235\u201342. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.003.","journal-title":"J Control Release"},{"issue":"14","key":"1887_CR73","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2174\/1389201019666180226152542","volume":"18","author":"C Zhang","year":"2018","unstructured":"Zhang C, Gu Z, Shen L, Liu X, Lin H. A dual targeting drug delivery system for penetrating blood-brain barrier and selectively delivering siRNA to neurons for Alzheimer\u2019s disease treatment. Curr Pharm Biotechnol. 2018;18(14):1124\u201331. https:\/\/doi.org\/10.2174\/1389201019666180226152542.","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"1887_CR74","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/ijms19103224","volume":"19","author":"S Al-azzawi","year":"2018","unstructured":"Al-azzawi S, Masheta D, Guildford AL, Phillips G, Santin M. Dendrimeric Poly(Epsilon-Lysine) delivery systems for the enhanced permeability of Flurbiprofen across the blood-brain barrier in Alzheimer\u2019s disease. Int J Mol Sci. 2018;19(10):3224. https:\/\/doi.org\/10.3390\/ijms19103224.","journal-title":"Int J Mol Sci"},{"key":"1887_CR75","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jconrel.2020.04.036","volume":"323","author":"R Sharma","year":"2020","unstructured":"Sharma R, et al. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury. J Control Release. 2020;323:361\u201375. https:\/\/doi.org\/10.1016\/j.jconrel.2020.04.036.","journal-title":"J Control Release"},{"key":"1887_CR76","doi-asserted-by":"publisher","unstructured":"Sharma A et al. Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders. Sci Adv. 2020;6(4). https:\/\/doi.org\/10.1126\/sciadv.aay8514.","DOI":"10.1126\/sciadv.aay8514"},{"issue":"8","key":"1887_CR77","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.7150\/thno.95476","volume":"14","author":"A Dhull","year":"2024","unstructured":"Dhull A, et al. Discovery of 2-deoxy glucose surfaced mixed layer dendrimer: a smart neuron targeted systemic drug delivery system for brain diseases. Theranostics. 2024;14(8):3221\u201345. https:\/\/doi.org\/10.7150\/thno.95476.","journal-title":"Theranostics"},{"key":"1887_CR78","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nano.2019.01.010","volume":"17","author":"E Aso","year":"2019","unstructured":"Aso E, et al. Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection. Nanomedicine. 2019;17:198\u2013209. https:\/\/doi.org\/10.1016\/j.nano.2019.01.010.","journal-title":"Nanomedicine"},{"issue":"2","key":"1887_CR79","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1039\/D0NR05958G","volume":"13","author":"L DeRidder","year":"2021","unstructured":"DeRidder L, et al. Dendrimer\u2013tesaglitazar conjugate induces a phenotype shift of microglia and enhances \u03b2-amyloid phagocytosis. Nanoscale. 2021;13(2):939\u201352. https:\/\/doi.org\/10.1039\/D0NR05958G.","journal-title":"Nanoscale"},{"issue":"1","key":"1887_CR80","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/s41598-024-51238-w","volume":"14","author":"S Zawadzki","year":"2024","unstructured":"Zawadzki S, et al. Synthesis and biophysical evaluation of carbosilane dendrimers as therapeutic siRNA carriers. Sci Rep. 2024;14(1):1615. https:\/\/doi.org\/10.1038\/s41598-024-51238-w.","journal-title":"Sci Rep"},{"key":"1887_CR81","doi-asserted-by":"publisher","unstructured":"Lu Y et al. Microthrombus\u2010Targeting Micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Adv Mater. 2019;31(21). https:\/\/doi.org\/10.1002\/adma.201808361.","DOI":"10.1002\/adma.201808361"},{"issue":"9","key":"1887_CR82","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3390\/molecules27092811","volume":"27","author":"BF Mogharbel","year":"2022","unstructured":"Mogharbel BF, et al. Biodegradable nanoparticles loaded with levodopa and curcumin for treatment of Parkinson\u2019s disease. Molecules. 2022;27(9):2811. https:\/\/doi.org\/10.3390\/molecules27092811.","journal-title":"Molecules"},{"issue":"4","key":"1887_CR83","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/bab.1751","volume":"66","author":"Z Mirzaie","year":"2019","unstructured":"Mirzaie Z, Ansari M, Kordestani SS, Rezaei MH, Mozafari M. Preparation and characterization of curcumin-loaded polymeric nanomicelles to interference with amyloidogenesis through glycation method. Biotechnol Appl Biochem. 2019;66(4):537\u201344. https:\/\/doi.org\/10.1002\/bab.1751.","journal-title":"Biotechnol Appl Biochem"},{"issue":"10","key":"1887_CR84","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1021\/acs.biomac.2c00761","volume":"24","author":"MS Haider","year":"2023","unstructured":"Haider MS, et al. Biological activity in vitro, absorption, BBB penetration, and tolerability of nanoformulation of BT44:RET agonist with disease-modifying potential for the treatment of neurodegeneration. Biomacromol. 2023;24(10):4348\u201365. https:\/\/doi.org\/10.1021\/acs.biomac.2c00761.","journal-title":"Biomacromol"},{"issue":"3","key":"1887_CR85","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acschemneuro.3c00625","volume":"15","author":"F Li","year":"2024","unstructured":"Li F, et al. Borneol-modified schisandrin B micelles cross the blood-brain barrier to treat Alzheimer\u2019s disease in aged mice. ACS Chem Neurosci. 2024;15(3):593\u2013607. https:\/\/doi.org\/10.1021\/acschemneuro.3c00625.","journal-title":"ACS Chem Neurosci"},{"key":"1887_CR86","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jconrel.2016.06.001","volume":"235","author":"C-Y Lin","year":"2016","unstructured":"Lin C-Y, Perche F, Ikegami M, Uchida S, Kataoka K, Itaka K. Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles. J Control Release. 2016;235:268\u201375. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.001.","journal-title":"J Control Release"},{"issue":"6","key":"1887_CR87","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1021\/acsnano.9b09991","volume":"14","author":"J Xie","year":"2020","unstructured":"Xie J, et al. Dual-sensitive nanomicelles enhancing systemic delivery of therapeutically active antibodies specifically into the Brain. ACS Nano. 2020;14(6):6729\u201342. https:\/\/doi.org\/10.1021\/acsnano.9b09991.","journal-title":"ACS Nano"},{"issue":"10","key":"1887_CR88","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/10837450.2024.2423833","volume":"29","author":"G \u0130\u011fdeli","year":"2024","unstructured":"\u0130\u011fdeli G, Fritzen L, Pietrzik CU, Temel BA. Preparation and characterization of poly(ethylene glycol)-poly( tert-butyl methacrylate) micelles as potential nanocarriers for donepezil. Pharm Dev Technol. 2024;29(10):1111\u201320. https:\/\/doi.org\/10.1080\/10837450.2024.2423833.","journal-title":"Pharm Dev Technol"},{"key":"1887_CR89","doi-asserted-by":"publisher","unstructured":"Lu Y et al. Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia. Adv Sci. 2019;6(4). https:\/\/doi.org\/10.1002\/advs.201801586.","DOI":"10.1002\/advs.201801586"},{"key":"1887_CR90","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neuro.2021.05.013","volume":"85","author":"M Sanati","year":"2021","unstructured":"Sanati M, et al. PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer\u2019s disease: potential participation of STIMs. Neurotoxicology. 2021;85:145\u201359. https:\/\/doi.org\/10.1016\/j.neuro.2021.05.013.","journal-title":"Neurotoxicology"},{"issue":"1","key":"1887_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12967-018-1712-3","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. The treatment value of IL-1\u03b2 monoclonal antibody under the targeting location of alpha-methyl-l-tryptophan and superparamagnetic iron oxide nanoparticles in an acute temporal lobe epilepsy model. J Transl Med. 2018;16(1):337. https:\/\/doi.org\/10.1186\/s12967-018-1712-3.","journal-title":"J Transl Med"},{"issue":"11","key":"1887_CR92","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1021\/acsbiomaterials.2c00865","volume":"8","author":"D D\u00edaz-Garc\u00eda","year":"2022","unstructured":"D\u00edaz-Garc\u00eda D, et al. Design of mesoporous silica nanoparticles for the treatment of amyotrophic lateral sclerosis (ALS) with a therapeutic cocktail based on leptin and Pioglitazone. ACS Biomater Sci Eng. 2022;8(11):4838\u201349. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00865.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"1887_CR93","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-020-77578-x","volume":"10","author":"MF Leyton-Jaimes","year":"2020","unstructured":"Leyton-Jaimes MF, et al. Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS. Sci Rep. 2020;10(1):20675. https:\/\/doi.org\/10.1038\/s41598-020-77578-x.","journal-title":"Sci Rep"},{"issue":"20","key":"1887_CR94","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1039\/D1TB00481F","volume":"9","author":"V Morales","year":"2021","unstructured":"Morales V, McConnell J, P\u00e9rez-Garnes M, Almendro N, Sanz R, Garc\u00eda-Mu\u00f1oz RA. l-Dopa release from mesoporous silica nanoparticles engineered through the concept of drug-structure-directing agents for Parkinson\u2019s disease. J Mater Chem B. 2021;9(20):4178\u201389. https:\/\/doi.org\/10.1039\/D1TB00481F.","journal-title":"J Mater Chem B"},{"key":"1887_CR95","doi-asserted-by":"publisher","first-page":"111608","DOI":"10.1016\/j.colsurfb.2021.111608","volume":"201","author":"MS Rodrigues","year":"2021","unstructured":"Rodrigues MS, et al. Nanotechnology as a therapeutic strategy to prevent neuropsychomotor alterations associated with hypercholesterolemia. Colloids Surf B Biointerfaces. 2021;201:111608. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111608.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"12","key":"1887_CR96","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1016\/j.bioactmat.2021.04.029","volume":"6","author":"BG Anand","year":"2021","unstructured":"Anand BG, et al. Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress \u03b2-amyloid aggregation and neuronal toxicity. Bioact Mater. 2021;6(12):4491\u2013505. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.04.029.","journal-title":"Bioact Mater"},{"key":"1887_CR97","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.2147\/IJN.S175076","volume":"13","author":"V Vio","year":"2018","unstructured":"Vio V, et al. Gold nanorods\/siRNA complex administration for knockdown of PARP-1: a potential treatment for perinatal asphyxia. Int J Nanomedicine. 2018;13:6839\u201354. https:\/\/doi.org\/10.2147\/IJN.S175076.","journal-title":"Int J Nanomedicine"},{"key":"1887_CR98","doi-asserted-by":"publisher","first-page":"102036","DOI":"10.1016\/j.eclinm.2023.102036","volume":"60","author":"S Vucic","year":"2023","unstructured":"Vucic S, et al. Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension. EClinicalMedicine. 2023;60:102036. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102036.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"1887_CR99","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.1021\/acsnano.0c00866","volume":"14","author":"P Valente","year":"2020","unstructured":"Valente P, et al. Conopeptide-functionalized nanoparticles selectively antagonize extrasynaptic N-Methyl- d-aspartate receptors and protect hippocampal neurons from excitotoxicity in vitro. ACS Nano. 2020;14(6):6866\u201377. https:\/\/doi.org\/10.1021\/acsnano.0c00866.","journal-title":"ACS Nano"},{"issue":"42","key":"1887_CR100","doi-asserted-by":"publisher","first-page":"47445","DOI":"10.1021\/acsami.2c14220","volume":"14","author":"C Morfill","year":"2022","unstructured":"Morfill C, et al. Nanostars carrying multifunctional neurotrophic dendrimers protect neurons in preclinical in vitro models of neurodegenerative Disorders. ACS Appl Mater Interfaces. 2022;14(42):47445\u201360. https:\/\/doi.org\/10.1021\/acsami.2c14220.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"38","key":"1887_CR101","doi-asserted-by":"publisher","first-page":"34725","DOI":"10.1021\/acsami.9b12319","volume":"11","author":"W Cong","year":"2019","unstructured":"Cong W, Bai R, Li Y-F, Wang L, Chen C. Selenium nanoparticles as an efficient nanomedicine for the therapy of Huntington\u2019s disease. ACS Appl Mater Interfaces. 2019;11(38):34725\u201335. https:\/\/doi.org\/10.1021\/acsami.9b12319.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1887_CR102","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actbio.2015.06.035","volume":"25","author":"T Yin","year":"2015","unstructured":"Yin T, Yang L, Liu Y, Zhou X, Sun J, Liu J. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood\u2013brain barrier permeability peptide-B6 peptide for potential use in Alzheimer\u2019s disease. Acta Biomater. 2015;25:172\u201383. https:\/\/doi.org\/10.1016\/j.actbio.2015.06.035.","journal-title":"Acta Biomater"},{"issue":"3","key":"1887_CR103","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/biology11030354","volume":"11","author":"NE Al Omairi","year":"2022","unstructured":"Al Omairi NE, et al. Selenium nanoparticles with prodigiosin rescue Hippocampal damage associated with Epileptic seizures induced by pentylenetetrazole in rats. Biology (Basel). 2022;11(3):354. https:\/\/doi.org\/10.3390\/biology11030354.","journal-title":"Biology (Basel)"},{"issue":"16","key":"1887_CR104","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1039\/C8TB02520G","volume":"7","author":"S Rao","year":"2019","unstructured":"Rao S, et al. Designing multifunctionalized selenium nanoparticles to reverse oxidative stress-induced spinal cord injury by attenuating ROS overproduction and mitochondria dysfunction. J Mater Chem B. 2019;7(16):2648\u201356. https:\/\/doi.org\/10.1039\/C8TB02520G.","journal-title":"J Mater Chem B"},{"issue":"6","key":"1887_CR105","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s12640-022-00590-8","volume":"40","author":"L Qiao","year":"2022","unstructured":"Qiao L, Chen Y, Dou X, Song X, Xu C. Biogenic selenium nanoparticles attenuate A\u03b225\u201335-induced toxicity in PC12 cells via Akt\/CREB\/BDNF signaling pathway. Neurotox Res. 2022;40(6):1869\u201381. https:\/\/doi.org\/10.1007\/s12640-022-00590-8.","journal-title":"Neurotox Res"},{"key":"1887_CR106","doi-asserted-by":"publisher","first-page":"102755","DOI":"10.1016\/j.nano.2024.102755","volume":"59","author":"H Zhao","year":"2024","unstructured":"Zhao H, Song J, Wang T, Fan X. Selenium nanoparticles decorated with polysaccharides from Sargassum fusiforme protects against 6-OHDA-induced neurotoxicity in PC12 cells and rat model of Parkinson\u2019s disease. Nanomedicine. 2024;59:102755. https:\/\/doi.org\/10.1016\/j.nano.2024.102755.","journal-title":"Nanomedicine"},{"issue":"26","key":"1887_CR107","doi-asserted-by":"publisher","first-page":"30261","DOI":"10.1021\/acsami.1c00690","volume":"13","author":"X Guo","year":"2021","unstructured":"Guo X, et al. Multifunctional selenium quantum dots for the treatment of Alzheimer\u2019s disease by reducing A\u03b2-neurotoxicity and oxidative stress and alleviate neuroinflammation. ACS Appl Mater Interfaces. 2021;13(26):30261\u201373. https:\/\/doi.org\/10.1021\/acsami.1c00690.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"19","key":"1887_CR108","doi-asserted-by":"publisher","first-page":"17581","DOI":"10.1021\/acsanm.3c02749","volume":"6","author":"N Kal\u010dec","year":"2023","unstructured":"Kal\u010dec N, et al. Selenium nanoparticles as potential drug-delivery systems for the treatment of Parkinson\u2019s disease. ACS Appl Nano Mater. 2023;6(19):17581\u201392. https:\/\/doi.org\/10.1021\/acsanm.3c02749.","journal-title":"ACS Appl Nano Mater"},{"key":"1887_CR109","doi-asserted-by":"publisher","first-page":"121904","DOI":"10.1016\/j.biomaterials.2022.121904","volume":"291","author":"X Li","year":"2022","unstructured":"Li X, et al. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke. Biomaterials. 2022;291:121904. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121904.","journal-title":"Biomaterials"},{"issue":"1","key":"1887_CR110","doi-asserted-by":"publisher","first-page":"e21789","DOI":"10.1016\/j.heliyon.2023.e21789","volume":"10","author":"X Yao","year":"2024","unstructured":"Yao X, Guan Y, Wang J, Wang D. Cerium oxide nanoparticles modulating the Parkinson\u2019s disease conditions: from the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles. Heliyon. 2024;10(1):e21789. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21789.","journal-title":"Heliyon"},{"issue":"10","key":"1887_CR111","doi-asserted-by":"publisher","first-page":"e0140387","DOI":"10.1371\/journal.pone.0140387","volume":"10","author":"L Fiorani","year":"2015","unstructured":"Fiorani L, Passacantando M, Santucci S, Di Marco S, Bisti S, Maccarone R. Cerium oxide nanoparticles reduce microglial activation and neurodegenerative events in light damaged retina. PLoS One. 2015;10(10):e0140387. https:\/\/doi.org\/10.1371\/journal.pone.0140387.","journal-title":"PLoS One"},{"key":"1887_CR112","doi-asserted-by":"publisher","unstructured":"Hanzha VV, Rozumna NM, Kravenska, Spivak MYa, Lukyanetz EA. The effect of cerium dioxide nanoparticles on the viability of hippocampal neurons in Alzheimer\u2019s disease modeling. Front Cell Neurosci. 2023;17. https:\/\/doi.org\/10.3389\/fncel.2023.1131168.","DOI":"10.3389\/fncel.2023.1131168"},{"issue":"10","key":"1887_CR113","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/cdd.2014.72","volume":"21","author":"JM Dowding","year":"2014","unstructured":"Dowding JM, et al. Cerium oxide nanoparticles protect against A\u03b2-induced mitochondrial fragmentation and neuronal cell death. Cell Death Differ. 2014;21(10):1622\u201332. https:\/\/doi.org\/10.1038\/cdd.2014.72.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1887_CR114","doi-asserted-by":"publisher","first-page":"497","DOI":"10.7150\/ntno.95863","volume":"8","author":"Y Khafajah","year":"2024","unstructured":"Khafajah Y, Shaheen M, El Natour D, Merheb M, Matar R, Borjac J. Neuroprotective effects of zinc oxide nanoparticles in a rotenone-induced mouse model of Parkinson\u2019s disease. Nanotheranostics. 2024;8(4):497\u2013505. https:\/\/doi.org\/10.7150\/ntno.95863.","journal-title":"Nanotheranostics"},{"issue":"9","key":"1887_CR115","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.1007\/s12035-018-0935-x","volume":"55","author":"JM Ashraf","year":"2018","unstructured":"Ashraf JM, et al. Inhibiting effect of zinc oxide nanoparticles on advanced glycation products and oxidative modifications: a potential tool to counteract oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2018;55(9):7438\u201352. https:\/\/doi.org\/10.1007\/s12035-018-0935-x.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1887_CR116","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1002\/tox.23903","volume":"38","author":"EM Moustafa","year":"2023","unstructured":"Moustafa EM, Moawed FSM, Elmaghraby DF. Luteolin\/ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA-124 by targeting C\/EBPA. Environ Toxicol. 2023;38(11):2691\u2013704. https:\/\/doi.org\/10.1002\/tox.23903.","journal-title":"Environ Toxicol"},{"issue":"41","key":"1887_CR117","doi-asserted-by":"publisher","first-page":"19437","DOI":"10.1039\/C9NR02648G","volume":"11","author":"B Choi","year":"2019","unstructured":"Choi B, et al. Highly selective microglial uptake of ceria\u2013zirconia nanoparticles for enhanced analgesic treatment of neuropathic pain. Nanoscale. 2019;11(41):19437\u201347. https:\/\/doi.org\/10.1039\/C9NR02648G.","journal-title":"Nanoscale"},{"issue":"1","key":"1887_CR118","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11481-024-10099-w","volume":"19","author":"SAA Morsy","year":"2024","unstructured":"Morsy SAA, Fathelbab MH, El-Sayed NS, El-Habashy SE, Aly RG, Harby SA. Doxycycline-loaded calcium phosphate nanoparticles with a pectin coat can ameliorate Lipopolysaccharide-induced neuroinflammation via enhancing AMPK. J Neuroimmune Pharmacol. 2024;19(1):2. https:\/\/doi.org\/10.1007\/s11481-024-10099-w.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1887_CR119","doi-asserted-by":"publisher","unstructured":"Berger M et al. Poly(N\u2010methyl\u2010N\u2010vinylacetamide): a strong alternative to PEG for Lipid\u2010based nanocarriers delivering siRNA. Adv Healthc Mater. 2024;13(8). https:\/\/doi.org\/10.1002\/adhm.202302712.","DOI":"10.1002\/adhm.202302712"},{"key":"1887_CR120","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jconrel.2024.06.051","volume":"372","author":"ML Borrajo","year":"2024","unstructured":"Borrajo ML, et al. Ionizable nanoemulsions for RNA delivery into the central nervous system \u2013 importance of diffusivity. J Control Release. 2024;372:295\u2013303. https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.051.","journal-title":"J Control Release"},{"issue":"4","key":"1887_CR121","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1021\/acsnano.3c09817","volume":"18","author":"M Gao","year":"2024","unstructured":"Gao M, et al. Targeted mRNA nanoparticles ameliorate blood-brain barrier disruption postischemic stroke by modulating microglia polarization. ACS Nano. 2024;18(4):3260\u201375. https:\/\/doi.org\/10.1021\/acsnano.3c09817.","journal-title":"ACS Nano"},{"key":"1887_CR122","doi-asserted-by":"publisher","unstructured":"Brouillard M, Barth\u00e9l\u00e9my P, Dehay B, Crauste-Manciet S, Desvergnes V. Nucleolipid acid-based nanocarriers restore neuronal lysosomal acidification defects. Front Chem. 2021;9. https:\/\/doi.org\/10.3389\/fchem.2021.736554.","DOI":"10.3389\/fchem.2021.736554"},{"issue":"7","key":"1887_CR123","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1073\/pnas.1912012117","volume":"117","author":"OA Marcos-Contreras","year":"2020","unstructured":"Marcos-Contreras OA, et al. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood\u2013brain barrier. Proc Natl Acad Sci. 2020;117(7):3405\u201314. https:\/\/doi.org\/10.1073\/pnas.1912012117.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1887_CR124","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12987-022-00315-1","volume":"19","author":"S Hernando","year":"2022","unstructured":"Hernando S, Nikolakopoulou P, Voulgaris D, Hernandez RM, Igartua M, Herland A. Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures. Fluids Barriers CNS. 2022;19(1):22. https:\/\/doi.org\/10.1186\/s12987-022-00315-1.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"1887_CR125","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JAD-190083","volume":"69","author":"S Sadegh Malvajerd","year":"2019","unstructured":"Sadegh Malvajerd S, et al. Neuroprotective potential of curcumin-loaded nanostructured lipid carrier in an animal model of Alzheimer\u2019s disease: behavioral and biochemical evidence. J Alzheimer\u2019s Dis. 2019;69(3):671\u201386. https:\/\/doi.org\/10.3233\/JAD-190083.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1887_CR126","doi-asserted-by":"publisher","unstructured":"Hernando S, Herran E, Hernandez RM, Igartua M. Nanostructured lipid carriers made of \u03a9-3 polyunsaturated fatty acids: in vitro evaluation of emerging nanocarriers to treat neurodegenerative diseases. Pharmaceutics. 2020;12(10):928. https:\/\/doi.org\/10.3390\/pharmaceutics12100928.","DOI":"10.3390\/pharmaceutics12100928"},{"key":"1887_CR127","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.colsurfb.2015.06.025","volume":"134","author":"F Meng","year":"2015","unstructured":"Meng F, et al. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer\u2019s disease. Colloids Surf B Biointerfaces. 2015;134:88\u201397. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.06.025.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1887_CR128","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.jddst.2021.102695","volume":"66","author":"S Lohan","year":"2021","unstructured":"Lohan S, et al. Galactosylated nanoconstructs of Berberine with enhanced Biopharmaceutical and cognitive potential: a preclinical evidence in Alzheimer \u2018s disease. J Drug Deliv Sci Technol. 2021;66:102695. https:\/\/doi.org\/10.1016\/j.jddst.2021.102695.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1887_CR129","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.actbio.2023.12.009","volume":"174","author":"J Xu","year":"2024","unstructured":"Xu J, et al. Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy. Acta Biomater. 2024;174:297\u2013313. https:\/\/doi.org\/10.1016\/j.actbio.2023.12.009.","journal-title":"Acta Biomater"},{"key":"1887_CR130","doi-asserted-by":"publisher","unstructured":"Athalye M, Teli D, Sharma A, Patel M. Anti\u2010epileptic drug\u2010lipid conjugates for delivery to the brain: in silico ADMET prediction, molecular docking and molecular dynamics simulations. ChemistrySelect. 2023;8(34). https:\/\/doi.org\/10.1002\/slct.202301701.","DOI":"10.1002\/slct.202301701"},{"key":"1887_CR131","doi-asserted-by":"publisher","unstructured":"Sela M et al. Brain\u2010targeted liposomes loaded with monoclonal antibodies reduce alpha\u2010synuclein aggregation and improve behavioral symptoms in Parkinson\u2019s Disease. Adv Mater. 2023;35(51). https:\/\/doi.org\/10.1002\/adma.202304654.","DOI":"10.1002\/adma.202304654"},{"key":"1887_CR132","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.2147\/IJN.S123442","volume":"11","author":"Y-C Kuo","year":"2016","unstructured":"Kuo Y-C, Lee Y-J. Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator- and apolipoprotein E-conjugated liposomes to the hippocampus. Int J Nanomedicine. 2016;11:6809\u201324. https:\/\/doi.org\/10.2147\/IJN.S123442.","journal-title":"Int J Nanomedicine"},{"key":"1887_CR133","doi-asserted-by":"publisher","unstructured":"Fu X-X et al. Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis. Drug Deliv. 2023;30(1). https:\/\/doi.org\/10.1080\/10717544.2023.2241664.","DOI":"10.1080\/10717544.2023.2241664"},{"issue":"13","key":"1887_CR134","doi-asserted-by":"publisher","first-page":"11013","DOI":"10.3390\/ijms241311013","volume":"24","author":"AL De La Torre","year":"2023","unstructured":"De La Torre AL, et al. Stealth liposomes encapsulating a potent ACAT1\/SOAT1 inhibitor F12511: pharmacokinetic, biodistribution, and toxicity studies in wild-type mice and efficacy studies in triple transgenic alzheimer\u2019s disease mice. Int J Mol Sci. 2023;24(13):11013. https:\/\/doi.org\/10.3390\/ijms241311013.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1887_CR135","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ymthe.2017.10.003","volume":"26","author":"S-S Kim","year":"2018","unstructured":"Kim S-S, Rait A, Garrido-Sanabria ER, Pirollo KF, Harford JB, Chang EH. Nanotherapeutics for gene modulation that prevents apoptosis in the brain and fatal neuroinflammation. Mol Ther. 2018;26(1):84\u201394. https:\/\/doi.org\/10.1016\/j.ymthe.2017.10.003.","journal-title":"Mol Ther"},{"issue":"1","key":"1887_CR136","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1080\/10717544.2022.2072543","volume":"29","author":"J Wang","year":"2022","unstructured":"Wang J, et al. Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer\u2019s disease. Drug Deliv. 2022;29(1):1648\u201362. https:\/\/doi.org\/10.1080\/10717544.2022.2072543.","journal-title":"Drug Deliv"},{"issue":"10","key":"1887_CR137","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/pharmaceutics14102163","volume":"14","author":"S Andrade","year":"2022","unstructured":"Andrade S, Loureiro JA, Pereira MC. Transferrin-functionalized liposomes for the delivery of gallic acid: a therapeutic approach for Alzheimer\u2019s disease. Pharmaceutics. 2022;14(10):2163. https:\/\/doi.org\/10.3390\/pharmaceutics14102163.","journal-title":"Pharmaceutics"},{"issue":"11","key":"1887_CR138","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1021\/acschemneuro.4c00109","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W, et al. Menthol-modified quercetin liposomes with brain-targeting function for the treatment of senescent Alzheimer\u2019s disease. ACS Chem Neurosci. 2024;15(11):2283\u201395. https:\/\/doi.org\/10.1021\/acschemneuro.4c00109.","journal-title":"ACS Chem Neurosci"},{"key":"1887_CR139","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.actbio.2019.01.065","volume":"87","author":"Y-C Kuo","year":"2019","unstructured":"Kuo Y-C, Chen C-L, Rajesh R. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration. Acta Biomater. 2019;87:207\u201322. https:\/\/doi.org\/10.1016\/j.actbio.2019.01.065.","journal-title":"Acta Biomater"},{"issue":"24","key":"1887_CR140","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1039\/D1BM01202A","volume":"9","author":"A Marino","year":"2021","unstructured":"Marino A, et al. Liposomes loaded with polyphenol-rich grape pomace extracts protect from neurodegeneration in a rotenone-based in vitro model of Parkinson\u2019s disease. Biomater Sci. 2021;9(24):8171\u201388. https:\/\/doi.org\/10.1039\/D1BM01202A.","journal-title":"Biomater Sci"},{"issue":"11","key":"1887_CR141","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3390\/pharmaceutics14112402","volume":"14","author":"S Giofr\u00e8","year":"2022","unstructured":"Giofr\u00e8 S, et al. Dual functionalized liposomes for selective delivery of poorly soluble drugs to inflamed brain regions. Pharmaceutics. 2022;14(11):2402. https:\/\/doi.org\/10.3390\/pharmaceutics14112402.","journal-title":"Pharmaceutics"},{"key":"1887_CR142","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejps.2018.10.006","volume":"127","author":"C Palazzo","year":"2019","unstructured":"Palazzo C, et al. Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies. Eur J Pharm Sci. 2019;127:52\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2018.10.006.","journal-title":"Eur J Pharm Sci"},{"key":"1887_CR143","doi-asserted-by":"publisher","unstructured":"Li N, Feng L, Tan Y, Xiang Y, Zhang R, Yang M. Preparation, characterization, pharmacokinetics and biodistribution of baicalin-loaded liposome on cerebral ischemia-reperfusion after i.v. administration in rats. Molecules. 2018;23(7):1747. https:\/\/doi.org\/10.3390\/molecules23071747.","DOI":"10.3390\/molecules23071747"},{"issue":"6","key":"1887_CR144","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/s41380-020-0742-4","volume":"26","author":"M Kahana","year":"2021","unstructured":"Kahana M, et al. Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson\u2019s disease. Mol Psychiatr. 2021;26(6):2626\u201332. https:\/\/doi.org\/10.1038\/s41380-020-0742-4.","journal-title":"Mol Psychiatr"},{"issue":"7","key":"1887_CR145","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1208\/s12249-021-02093-9","volume":"22","author":"J Wan","year":"2021","unstructured":"Wan J, et al. Geniposide-loaded liposomes for brain targeting: development, evaluation, and in vivo studies. AAPS PharmSciTech. 2021;22(7):222. https:\/\/doi.org\/10.1208\/s12249-021-02093-9.","journal-title":"AAPS PharmSciTech"},{"key":"1887_CR146","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.2147\/IJN.S468942","volume":"19","author":"Z Ou","year":"2024","unstructured":"Ou Z et al. Key lipoprotein receptor targeted echinacoside-liposomes effective against Parkinson\u2019s disease in mice model. Int J Nanomedicine. 2024;19:8463\u201383. https:\/\/doi.org\/10.2147\/IJN.S468942.","journal-title":"Int J Nanomedicine"},{"issue":"20","key":"1887_CR147","doi-asserted-by":"publisher","first-page":"e39607","DOI":"10.1016\/j.heliyon.2024.e39607","volume":"10","author":"N Wang","year":"2024","unstructured":"Wang N, et al. Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-\u03b2 accumulation in AppNL\u2212G-F mice. Heliyon. 2024;10(20):e39607. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39607.","journal-title":"Heliyon"},{"key":"1887_CR148","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jconrel.2024.01.059","volume":"367","author":"R Meng","year":"2024","unstructured":"Meng R, Yang X, Li Y, Zhang Q. Extending dual-targeting upper-limit in liposomal delivery of lithospermic acid B for Alzheimer\u2019s mitochondrial revitalization. J Control Release. 2024;367:604\u201319. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.059.","journal-title":"J Control Release"},{"issue":"9","key":"1887_CR149","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/03639045.2023.2252062","volume":"49","author":"M-H Chen","year":"2023","unstructured":"Chen M-H, et al. ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer\u2019s disease in APP\/PS-1 mice. Drug Dev Ind Pharm. 2023;49(9):559\u201371. https:\/\/doi.org\/10.1080\/03639045.2023.2252062.","journal-title":"Drug Dev Ind Pharm"},{"key":"1887_CR150","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.colsurfb.2017.10.062","volume":"161","author":"G Graverini","year":"2018","unstructured":"Graverini G, et al. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. Colloids Surf B Biointerfaces. 2018;161:302\u201313. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.10.062.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1887_CR151","doi-asserted-by":"publisher","unstructured":"Scioli-Montoto S et al. Novel phenobarbital-loaded nanostructured lipid carriers for epilepsy treatment: from QbD to in vivo evaluation. Front Chem. 2022;10. https:\/\/doi.org\/10.3389\/fchem.2022.908386.","DOI":"10.3389\/fchem.2022.908386"},{"key":"1887_CR152","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.matdes.2021.110012","volume":"209","author":"\u00d6 \u015een","year":"2021","unstructured":"\u015een \u00d6, et al. Evaluation of the therapeutic potential of resveratrol-loaded nanostructured lipid carriers on autosomal recessive spastic ataxia of Charlevoix-Saguenay patient-derived fibroblasts. Mater Des. 2021;209:110012. https:\/\/doi.org\/10.1016\/j.matdes.2021.110012.","journal-title":"Mater Des"},{"key":"1887_CR153","doi-asserted-by":"publisher","first-page":"111084","DOI":"10.1016\/j.cbi.2024.111084","volume":"397","author":"A Ghosh","year":"2024","unstructured":"Ghosh A, Khanam N, Nath D. Solid lipid nanoparticle: a potent vehicle of the kaempferol for brain delivery through the blood-brain barrier in the focal cerebral ischemic rat. Chem Biol Interact. 2024;397:111084. https:\/\/doi.org\/10.1016\/j.cbi.2024.111084.","journal-title":"Chem Biol Interact"},{"key":"1887_CR154","doi-asserted-by":"publisher","unstructured":"Khishvand MA, Yeganeh EM, Zarei M, Soleimani M, Mohammadi M, Mahjub R. Development, statistical optimization, and characterization of resveratrol\u2010containing solid lipid nanoparticles (SLNs) and fetermination of the efficacy in reducing neurodegenerative symptoms related to Alzheimer\u2019s disease: in vitro and in vivo study. Biomed Res Int. 2024;2024(1). https:\/\/doi.org\/10.1155\/2024\/7877265.","DOI":"10.1155\/2024\/7877265"},{"issue":"3","key":"1887_CR155","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/03639045.2013.861478","volume":"41","author":"Z Liu","year":"2015","unstructured":"Liu Z, et al. Preparation and evaluation of baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB. Drug Dev Ind Pharm. 2015;41(3):353\u201361. https:\/\/doi.org\/10.3109\/03639045.2013.861478.","journal-title":"Drug Dev Ind Pharm"},{"issue":"9","key":"1887_CR156","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/molecules29091907","volume":"29","author":"S Yu","year":"2024","unstructured":"Yu S, et al. Electropositive citric acid-polyethyleneimine carbon dots carrying the PINK1 gene regulate ATP-related metabolic dysfunction in APP\/PS1-N2a cells. Molecules. 2024;29(9):1907. https:\/\/doi.org\/10.3390\/molecules29091907.","journal-title":"Molecules"},{"issue":"46","key":"1887_CR157","doi-asserted-by":"publisher","first-page":"22387","DOI":"10.1039\/C9NR08194A","volume":"11","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et al. Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood\u2013brain barrier and inhibitors of \u03b2-amyloid. Nanoscale. 2019;11(46):22387\u201397. https:\/\/doi.org\/10.1039\/C9NR08194A.","journal-title":"Nanoscale"},{"issue":"2","key":"1887_CR158","doi-asserted-by":"publisher","first-page":"153","DOI":"10.59249\/EWOI2166","volume":"97","author":"S Khan","year":"2024","unstructured":"Khan S, et al. Therapeutic potential of nitrogen-doped rutin-bound glucose carbon dots for Alzheimer\u2019s disease. Yale J Biol Med. 2024;97(2):153\u201364. https:\/\/doi.org\/10.59249\/EWOI2166.","journal-title":"Yale J Biol Med"},{"key":"1887_CR159","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcis.2024.05.072","volume":"670","author":"SM ElMorsy","year":"2024","unstructured":"ElMorsy SM, et al. Graphene acid quantum dots: A highly active multifunctional carbon nano material that intervene in the trajectory towards neurodegeneration. J Colloid Interface Sci. 2024;670:357\u201363. https:\/\/doi.org\/10.1016\/j.jcis.2024.05.072.","journal-title":"J Colloid Interface Sci"},{"key":"1887_CR160","doi-asserted-by":"publisher","first-page":"119752","DOI":"10.1016\/j.biomaterials.2019.119752","volume":"232","author":"C Ren","year":"2020","unstructured":"Ren C, Li D, Zhou Q, Hu X. Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1\/M2 microglial polarization in an Alzheimer\u2019s disease model. Biomaterials. 2020;232:119752. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119752.","journal-title":"Biomaterials"},{"key":"1887_CR161","doi-asserted-by":"publisher","first-page":"119849","DOI":"10.1016\/j.biomaterials.2020.119849","volume":"240","author":"J Zhao","year":"2020","unstructured":"Zhao J, et al. Nanocage encapsulation improves antiepileptic efficiency of phenytoin. Biomaterials. 2020;240:119849. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119849.","journal-title":"Biomaterials"},{"issue":"7","key":"1887_CR162","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.1021\/acsami.3c17092","volume":"16","author":"L Biswal","year":"2024","unstructured":"Biswal L, Sardoiwala MN, Kushwaha AC, Mukherjee S, Karmakar S. Melatonin-loaded nanoparticles augment mitophagy to retard Parkinson\u2019s disease. ACS Appl Mater Interfaces. 2024;16(7):8417\u201329. https:\/\/doi.org\/10.1021\/acsami.3c17092.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1887_CR163","doi-asserted-by":"publisher","first-page":"131739","DOI":"10.1016\/j.ijbiomac.2024.131739","volume":"268","author":"L Duan","year":"2024","unstructured":"Duan L, et al. Glucose-modified BSA\/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer\u2019s disease models. Int J Biol Macromol. 2024;268:131739. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131739.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"1887_CR164","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.1021\/acsami.3c13849","volume":"16","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. Enhancing neuroprotection in mouse model of Parkinson\u2019s disease through protein nanosystem conjugation with ApoE peptide for miR-124 delivery. ACS Appl Mater Interfaces. 2024;16(7):8199\u2013212. https:\/\/doi.org\/10.1021\/acsami.3c13849.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1887_CR165","doi-asserted-by":"publisher","unstructured":"Moura RP, Carvalho ED, Martins C, des Rieux A, P\u00eago AP, Sarmento B. Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders. J Control Release. 2023;358:43\u201358. https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.034.","DOI":"10.1016\/j.jconrel.2023.04.034"},{"issue":"43","key":"1887_CR166","doi-asserted-by":"publisher","first-page":"48416","DOI":"10.1021\/acsami.2c13322","volume":"14","author":"B Li","year":"2022","unstructured":"Li B, et al. Alleviating neuroinflammation through photothermal conjugated polymer nanoparticles by regulating reactive oxygen species and Ca2+ signaling. ACS Appl Mater Interfaces. 2022;14(43):48416\u201325. https:\/\/doi.org\/10.1021\/acsami.2c13322.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1887_CR167","doi-asserted-by":"publisher","unstructured":"Ji W et al. Self\u2010catalytic small interfering RNA nanocarriers for synergistic treatment of neurodegenerative diseases. Adv Mater. 2022;34(1). https:\/\/doi.org\/10.1002\/adma.202105711.","DOI":"10.1002\/adma.202105711"},{"issue":"22","key":"1887_CR168","doi-asserted-by":"publisher","first-page":"14348","DOI":"10.1021\/acsnano.4c00480","volume":"18","author":"P Yang","year":"2024","unstructured":"Yang P, et al. Precise modulation of pericyte dysfunction by a multifunctional nanoprodrug to ameliorate Alzheimer\u2019s disease. ACS Nano. 2024;18(22):14348\u201366. https:\/\/doi.org\/10.1021\/acsnano.4c00480.","journal-title":"ACS Nano"},{"issue":"26","key":"1887_CR169","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.1007\/s00216-022-04285-z","volume":"414","author":"D Vicente-Zurdo","year":"2022","unstructured":"Vicente-Zurdo D, Rodr\u00edguez-Bl\u00e1zquez S, G\u00f3mez-Mej\u00eda E, Rosales-Conrado N, Le\u00f3n-Gonz\u00e1lez ME, Madrid Y. Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer\u2019s disease. Anal Bioanal Chem. 2022;414(26):7573\u201384. https:\/\/doi.org\/10.1007\/s00216-022-04285-z.","journal-title":"Anal Bioanal Chem"},{"key":"1887_CR170","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jddst.2018.10.020","volume":"49","author":"R Safdar","year":"2019","unstructured":"Safdar R, Omar AA, Arunagiri A, Regupathi I, Thanabalan M. Potential of chitosan and its derivatives for controlled drug release applications \u2013 a review. J Drug Deliv Sci Technol. 2019;49:642\u201359. https:\/\/doi.org\/10.1016\/j.jddst.2018.10.020.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1887_CR171","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijbiomac.2019.06.062","volume":"136","author":"AM Abdelgawad","year":"2019","unstructured":"Abdelgawad AM, Hudson SM. Chitosan nanoparticles: Polyphosphates cross-linking and protein delivery properties. Int J Biol Macromol. 2019;136:133\u201342. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.06.062.","journal-title":"Int J Biol Macromol"},{"issue":"16","key":"1887_CR172","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25(16):3731. https:\/\/doi.org\/10.3390\/molecules25163731.","journal-title":"Molecules"},{"issue":"1\u20132","key":"1887_CR173","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2014.11.042","volume":"482","author":"N Grabowski","year":"2015","unstructured":"Grabowski N, et al. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages. Int J Pharm. 2015;482(1\u20132):75\u201383. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.11.042.","journal-title":"Int J Pharm"},{"key":"1887_CR174","doi-asserted-by":"publisher","unstructured":"Jarai BM, Kolewe EL, Stillman ZS, Raman N, Fromen CA. Polymeric nanoparticles. In: Nanoparticles for Biomedical Applications. Elsevier; 2020. pp. 303\u2013324. https:\/\/doi.org\/10.1016\/B978-0-12-816662-8.00018-7.","DOI":"10.1016\/B978-0-12-816662-8.00018-7"},{"issue":"3","key":"1887_CR175","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/2211738506666180706121515","volume":"6","author":"C Fornaguera","year":"2018","unstructured":"Fornaguera C, Solans C. Characterization of polymeric nanoparticle dispersions for biomedical applications: size, surface charge and stability. Pharm Nanotechnol. 2018;6(3):147\u201364. https:\/\/doi.org\/10.2174\/2211738506666180706121515.","journal-title":"Pharm Nanotechnol"},{"key":"1887_CR176","doi-asserted-by":"publisher","first-page":"102125","DOI":"10.1016\/j.nano.2019.102125","volume":"24","author":"F Anversa Dimer","year":"2020","unstructured":"Anversa Dimer F, et al. PLGA nanocapsules improve the delivery of clarithromycin to kill intracellular Staphylococcus aureus and Mycobacterium abscessus. Nanomedicine. 2020;24:102125. https:\/\/doi.org\/10.1016\/j.nano.2019.102125.","journal-title":"Nanomedicine"},{"issue":"7","key":"1887_CR177","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/nn3004372","volume":"6","author":"B Le Droumaguet","year":"2012","unstructured":"Le Droumaguet B, et al. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer\u2019s disease. ACS Nano. 2012;6(7):5866\u201379. https:\/\/doi.org\/10.1021\/nn3004372.","journal-title":"ACS Nano"},{"issue":"5\u20136","key":"1887_CR178","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/1061186X.2019.1588280","volume":"27","author":"C Vauthier","year":"2019","unstructured":"Vauthier C. A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles. J Drug Target. 2019;27(5\u20136):502\u201324. https:\/\/doi.org\/10.1080\/1061186X.2019.1588280.","journal-title":"J Drug Target"},{"issue":"1","key":"1887_CR179","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/02652048.2012.692491","volume":"30","author":"J Kreuter","year":"2013","unstructured":"Kreuter J. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J Microencapsul. 2013;30(1):49\u201354. https:\/\/doi.org\/10.3109\/02652048.2012.692491.","journal-title":"J Microencapsul"},{"issue":"1","key":"1887_CR180","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1049\/nbt2.12018","volume":"15","author":"A Bose","year":"2021","unstructured":"Bose A, Roy Burman D, Sikdar B, Patra P. Nanomicelles: Types, properties and applications in drug delivery. IET Nanobiotechnol. 2021;15(1):19\u201327. https:\/\/doi.org\/10.1049\/nbt2.12018.","journal-title":"IET Nanobiotechnol"},{"issue":"12","key":"1887_CR181","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/polym14122510","volume":"14","author":"S Perumal","year":"2022","unstructured":"Perumal S, Atchudan R, Lee W. A review of polymeric micelles and their applications. Polymers (Basel). 2022;14(12):2510. https:\/\/doi.org\/10.3390\/polym14122510.","journal-title":"Polymers (Basel)"},{"key":"1887_CR182","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.031.","journal-title":"J Control Release"},{"issue":"1","key":"1887_CR183","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1556-276X-9-247","volume":"9","author":"E Abbasi","year":"2014","unstructured":"Abbasi E, et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 2014;9(1):247. https:\/\/doi.org\/10.1186\/1556-276X-9-247.","journal-title":"Nanoscale Res Lett"},{"issue":"22","key":"1887_CR184","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.3390\/polym15224369","volume":"15","author":"M P\u00e9rez-Ferreiro","year":"2023","unstructured":"P\u00e9rez-Ferreiro M, Abelairas AM, Criado A, G\u00f3mez IJ, Mosquera J. Dendrimers: exploring their wide structural variety and applications. Polymers (Basel). 2023;15(22):4369. https:\/\/doi.org\/10.3390\/polym15224369.","journal-title":"Polymers (Basel)"},{"key":"1887_CR185","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","volume":"12","author":"F Abedi-Gaballu","year":"2018","unstructured":"Abedi-Gaballu F, et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl Mater Today. 2018;12:177\u201390. https:\/\/doi.org\/10.1016\/j.apmt.2018.05.002.","journal-title":"Appl Mater Today"},{"issue":"12","key":"1887_CR186","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/biom9120790","volume":"9","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Liu C, Pang Z. Dendrimer-based drug delivery systems for brain targeting. Biomolecules. 2019;9(12):790. https:\/\/doi.org\/10.3390\/biom9120790.","journal-title":"Biomolecules"},{"issue":"8","key":"1887_CR187","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/biom9080330","volume":"9","author":"A Janaszewska","year":"2019","unstructured":"Janaszewska A, Lazniewska J, Trzepi\u0144ski P, Marcinkowska M, Klajnert-Maculewicz B. Cytotoxicity of dendrimers. Biomolecules. 2019;9(8):330. https:\/\/doi.org\/10.3390\/biom9080330.","journal-title":"Biomolecules"},{"issue":"1","key":"1887_CR188","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s11671-023-03943-0","volume":"18","author":"G Unnikrishnan","year":"2023","unstructured":"Unnikrishnan G, Joy A, Megha M, Kolanthai E, Senthilkumar M. Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. Discover Nano. 2023;18(1):157. https:\/\/doi.org\/10.1186\/s11671-023-03943-0.","journal-title":"Discover Nano"},{"key":"1887_CR189","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","volume":"138","author":"SM Dadfar","year":"2019","unstructured":"Dadfar SM, et al. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302\u201325. https:\/\/doi.org\/10.1016\/j.addr.2019.01.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"16","key":"1887_CR190","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.biomaterials.2007.01.043","volume":"28","author":"TR Pisanic","year":"2007","unstructured":"Pisanic TR, Blackwell JD, Shubayev VI, Fi\u00f1ones RR, Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials. 2007;28(16):2572\u201381. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.01.043.","journal-title":"Biomaterials"},{"issue":"4","key":"1887_CR191","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1021\/cr2002596","volume":"112","author":"M Mahmoudi","year":"2012","unstructured":"Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev. 2012;112(4):2323\u201338. https:\/\/doi.org\/10.1021\/cr2002596.","journal-title":"Chem Rev"},{"issue":"1","key":"1887_CR192","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.3402\/nano.v1i0.5358","volume":"1","author":"N Singh","year":"2010","unstructured":"Singh N, Jenkins GJS, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1(1):5358. https:\/\/doi.org\/10.3402\/nano.v1i0.5358.","journal-title":"Nano Rev"},{"key":"1887_CR193","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.2147\/IJN.S321984","volume":"16","author":"H Wei","year":"2021","unstructured":"Wei H, Hu Y, Wang J, Gao X, Qian X, Tang M. Superparamagnetic iron oxide nanoparticles: cytotoxicity, metabolism, and cellular behavior in biomedicine applications. Int J Nanomedicine. 2021;16:6097\u2013113. https:\/\/doi.org\/10.2147\/IJN.S321984.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1887_CR194","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"B Xu","year":"2023","unstructured":"Xu B, Li S, Shi R, Liu H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8(1):435. https:\/\/doi.org\/10.1038\/s41392-023-01654-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1887_CR195","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/molecules23010047","volume":"23","author":"M Vallet-Reg\u00ed","year":"2017","unstructured":"Vallet-Reg\u00ed M, Colilla M, Izquierdo-Barba I, Manzano M. Mesoporous silica nanoparticles for drug delivery: current insights. Molecules. 2017;23(1):47. https:\/\/doi.org\/10.3390\/molecules23010047.","journal-title":"Molecules"},{"key":"1887_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/608548","volume":"2012","author":"M Vallet-Reg\u00ed","year":"2012","unstructured":"Vallet-Reg\u00ed M. Mesoporous silica nanoparticles: their projection in nanomedicine. ISRN Mater Sci. 2012;2012:1\u201320. https:\/\/doi.org\/10.5402\/2012\/608548.","journal-title":"ISRN Mater Sci"},{"issue":"7","key":"1887_CR197","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/smll.200800461","volume":"5","author":"D Napierska","year":"2009","unstructured":"Napierska D, et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small. 2009;5(7):846\u201353. https:\/\/doi.org\/10.1002\/smll.200800461.","journal-title":"Small"},{"issue":"17","key":"1887_CR198","doi-asserted-by":"publisher","first-page":"16308","DOI":"10.1021\/acsnano.3c07621","volume":"17","author":"A Noureddine","year":"2023","unstructured":"Noureddine A, et al. Future of mesoporous silica nanoparticles in nanomedicine: protocol for reproducible synthesis, characterization, lipid coating, and loading of therapeutics (Chemotherapeutic, proteins, siRNA and mRNA). ACS Nano. 2023;17(17):16308\u201325. https:\/\/doi.org\/10.1021\/acsnano.3c07621.","journal-title":"ACS Nano"},{"issue":"13","key":"1887_CR199","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.3390\/ijms23137400","volume":"23","author":"MA Dheyab","year":"2022","unstructured":"Dheyab MA, et al. Monodisperse gold nanoparticles: a review on synthesis and their application in modern medicine. Int J Mol Sci. 2022;23(13):7400. https:\/\/doi.org\/10.3390\/ijms23137400.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1887_CR200","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/mt.2014.30","volume":"22","author":"Y Ding","year":"2014","unstructured":"Ding Y, et al. Gold nanoparticles for nucleic acid delivery. Mol Ther. 2014;22(6):1075\u201383. https:\/\/doi.org\/10.1038\/mt.2014.30.","journal-title":"Mol Ther"},{"issue":"7","key":"1887_CR201","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.3390\/ijms25074057","volume":"25","author":"\u0141 Ni\u017cnik","year":"2024","unstructured":"Ni\u017cnik \u0141, et al. Gold nanoparticles (AuNPs)\u2014toxicity, Safety and Green Synthesis: A Critical Review. Int J Mol Sci. 2024;25(7):4057. https:\/\/doi.org\/10.3390\/ijms25074057.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1887_CR202","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/pharmaceutics16101332","volume":"16","author":"J Georgeous","year":"2024","unstructured":"Georgeous J, AlSawaftah N, Abuwatfa WH, Husseini GA. Review of gold nanoparticles: asynthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy. Pharmaceutics. 2024;16(10):1332. https:\/\/doi.org\/10.3390\/pharmaceutics16101332.","journal-title":"Pharmaceutics"},{"issue":"6","key":"1887_CR203","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10856-017-5902-y","volume":"28","author":"A Wo\u017aniak","year":"2017","unstructured":"Wo\u017aniak A, et al. Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications. J Mater Sci Mater Med. 2017;28(6):92. https:\/\/doi.org\/10.1007\/s10856-017-5902-y.","journal-title":"J Mater Sci Mater Med"},{"issue":"4","key":"1887_CR204","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/molecules29040801","volume":"29","author":"S Sampath","year":"2024","unstructured":"Sampath S, Sunderam V, Manjusha M, Dlamini Z, Lawrance AV. Selenium nanoparticles: a comprehensive examination of synthesis techniques and their diverse applications in medical research and toxicology studies. Molecules. 2024;29(4):801. https:\/\/doi.org\/10.3390\/molecules29040801.","journal-title":"Molecules"},{"key":"1887_CR205","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bmt.2023.12.001","volume":"6","author":"KK Karthik","year":"2024","unstructured":"Karthik KK, Cheriyan BV, Rajeshkumar S, Gopalakrishnan M. A review on selenium nanoparticles and their biomedical applications. Biomed Technol. 2024;6:61\u201374. https:\/\/doi.org\/10.1016\/j.bmt.2023.12.001.","journal-title":"Biomed Technol"},{"issue":"3","key":"1887_CR206","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1038\/am.2013.88","volume":"6","author":"C Xu","year":"2014","unstructured":"Xu C, Qu X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater. 2014;6(3):e90\u2013e90. https:\/\/doi.org\/10.1038\/am.2013.88.","journal-title":"NPG Asia Mater"},{"key":"1887_CR207","doi-asserted-by":"publisher","unstructured":"Let\u2019s talk about lipid nanoparticles. Nat Rev Mater. 2021;6(2):99\u201399. https:\/\/doi.org\/10.1038\/s41578-021-00281-4.","DOI":"10.1038\/s41578-021-00281-4"},{"key":"1887_CR208","doi-asserted-by":"publisher","unstructured":"Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. https:\/\/doi.org\/10.1016\/j.addr.2022.114416.","DOI":"10.1016\/j.addr.2022.114416"},{"issue":"5","key":"1887_CR209","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"issue":"3","key":"1887_CR210","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/molecules28031498","volume":"28","author":"GYW Tseu","year":"2023","unstructured":"Tseu GYW, Kamaruzaman KA. A review of different types of liposomes and their advancements as a form of gene therapy treatment for Breast Cancer. Molecules. 2023;28(3):1498. https:\/\/doi.org\/10.3390\/molecules28031498.","journal-title":"Molecules"},{"key":"1887_CR211","doi-asserted-by":"publisher","first-page":"130891","DOI":"10.1016\/j.colsurfa.2022.130891","volume":"661","author":"M Hohokabe","year":"2023","unstructured":"Hohokabe M, et al. Modification of liposomes composed of a cationic lipid TMAG and an anionic lipid DSPG with a PEGylated lipid based on the investigation of lipid structures. Colloids Surf A Physicochem Eng Asp. 2023;661:130891. https:\/\/doi.org\/10.1016\/j.colsurfa.2022.130891.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"1887_CR212","doi-asserted-by":"publisher","unstructured":"Pink DL et al. On the structure of solid lipid nanoparticles. Small. 2019;15(45). https:\/\/doi.org\/10.1002\/smll.201903156.","DOI":"10.1002\/smll.201903156"},{"issue":"3","key":"1887_CR213","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"R Paliwal","year":"2020","unstructured":"Paliwal R, Paliwal SR, Kenwat R, Das Kurmi B, Sahu MK. Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat. 2020;30(3):179\u201394. https:\/\/doi.org\/10.1080\/13543776.2020.1720649.","journal-title":"Expert Opin Ther Pat"},{"issue":"7","key":"1887_CR214","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1021\/la001362n","volume":"17","author":"A Forgiarini","year":"2001","unstructured":"Forgiarini A, Esquena J, Gonz\u00e1lez C, Solans C. Formation of nano-emulsions by low-energy emulsification methods at constant temperature. Langmuir. 2001;17(7):2076\u201383. https:\/\/doi.org\/10.1021\/la001362n.","journal-title":"Langmuir"},{"issue":"7","key":"1887_CR215","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1007\/s00289-021-03729-3","volume":"79","author":"B Ojha","year":"2022","unstructured":"Ojha B, Jain VK, Gupta S, Talegaonkar S, Jain K. Nanoemulgel: a promising novel formulation for treatment of skin ailments. Polym Bull. 2022;79(7):4441\u201365. https:\/\/doi.org\/10.1007\/s00289-021-03729-3.","journal-title":"Polym Bull"},{"issue":"12","key":"1887_CR216","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1021\/acscentsci.0c01306","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Li R, Yang B. Carbon dots: a new type of carbon-based nanomaterial with wide applications. ACS Cent Sci. 2020;6(12):2179\u201395. https:\/\/doi.org\/10.1021\/acscentsci.0c01306.","journal-title":"ACS Cent Sci"},{"key":"1887_CR217","doi-asserted-by":"publisher","unstructured":"Guan X et al. Emerging trends of carbon\u2010based quantum dots: nanoarchitectonics and applications. Small. 2023;19(17). https:\/\/doi.org\/10.1002\/smll.202207181.","DOI":"10.1002\/smll.202207181"},{"key":"1887_CR218","doi-asserted-by":"publisher","unstructured":"Ozyurt D, Al Kobaisi M, Hocking RK, Fox B. Properties, synthesis, and applications of carbon dots: a review. Carbon Trends. 2023;12:100276. https:\/\/doi.org\/10.1016\/j.cartre.2023.100276.","DOI":"10.1016\/j.cartre.2023.100276"},{"issue":"4","key":"1887_CR219","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/nano11040935","volume":"11","author":"MR Biswal","year":"2021","unstructured":"Biswal MR, Bhatia S. Carbon dot nanoparticles: exploring the potential use for gene delivery in ophthalmic diseases. Nanomaterials. 2021;11(4):935. https:\/\/doi.org\/10.3390\/nano11040935.","journal-title":"Nanomaterials"},{"issue":"82","key":"1887_CR220","doi-asserted-by":"publisher","first-page":"78595","DOI":"10.1039\/C6RA13016J","volume":"6","author":"L Hu","year":"2016","unstructured":"Hu L, et al. Metal-based quantum dots: synthesis, surface modification, transport and fate in aquatic environments and toxicity to microorganisms. RSC Adv. 2016;6(82):78595\u2013610. https:\/\/doi.org\/10.1039\/C6RA13016J.","journal-title":"RSC Adv"},{"issue":"5","key":"1887_CR221","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.addr.2012.09.036","volume":"65","author":"CE Probst","year":"2013","unstructured":"Probst CE, Zrazhevskiy P, Bagalkot V, Gao X. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev. 2013;65(5):703\u201318. https:\/\/doi.org\/10.1016\/j.addr.2012.09.036.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1887_CR222","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1080\/10942912.2023.2261662","volume":"26","author":"A Saif","year":"2023","unstructured":"Saif A, et al. Recent advances in protein-based nanoparticles and their applications in the delivery of bioactive compounds. Int J Food Prop. 2023;26(2):2866\u201380. https:\/\/doi.org\/10.1080\/10942912.2023.2261662.","journal-title":"Int J Food Prop"},{"issue":"5","key":"1887_CR223","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.ajps.2023.100857","volume":"18","author":"R Wang","year":"2023","unstructured":"Wang R, et al. Nanotechnologies meeting natural sources: Engineered lipoproteins for precise brain disease theranostics. Asian J Pharm Sci. 2023;18(5):100857. https:\/\/doi.org\/10.1016\/j.ajps.2023.100857.","journal-title":"Asian J Pharm Sci"},{"issue":"7","key":"1887_CR224","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/pharmaceutics12070604","volume":"12","author":"S Hong","year":"2020","unstructured":"Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-based nanoparticles as drug delivery systems. Pharmaceutics. 2020;12(7):604. https:\/\/doi.org\/10.3390\/pharmaceutics12070604.","journal-title":"Pharmaceutics"},{"key":"1887_CR225","doi-asserted-by":"publisher","unstructured":"Kaltbeitzel J, Wich PR. Protein\u2010based nanoparticles: from drug delivery to imaging, nanocatalysis and protein therapy. Angew Chem Int Ed. 2023;62(44). https:\/\/doi.org\/10.1002\/anie.202216097.","DOI":"10.1002\/anie.202216097"},{"issue":"28","key":"1887_CR226","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1002\/adma.201200653","volume":"24","author":"MJ Sailor","year":"2012","unstructured":"Sailor MJ, Park J. Hybrid nanoparticles for detection and treatment of cancer. Adv Mater. 2012;24(28):3779\u2013802. https:\/\/doi.org\/10.1002\/adma.201200653.","journal-title":"Adv Mater"},{"key":"1887_CR227","doi-asserted-by":"publisher","unstructured":"Lotey NK, Pednekar S, Chaughule R. Hybrid nanoparticles in biomedical applications. In: Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications. Cham: Springer International Publishing; 2022. pp. 365\u2013400. https:\/\/doi.org\/10.1007\/978-3-031-09636-5_13.","DOI":"10.1007\/978-3-031-09636-5_13"},{"key":"1887_CR228","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.09.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"1887_CR229","doi-asserted-by":"publisher","unstructured":"Pad\u00edn-Gonz\u00e1lez E et al. Understanding the role and impact of poly (Ethylene Glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines. Front Bioeng Biotechnol. 2022;10. https:\/\/doi.org\/10.3389\/fbioe.2022.882363.","DOI":"10.3389\/fbioe.2022.882363"},{"issue":"24","key":"1887_CR230","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L, et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13(24):10748\u201364. https:\/\/doi.org\/10.1039\/D1NR02065J.","journal-title":"Nanoscale"},{"key":"1887_CR231","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","volume":"154\u2013155","author":"GT Kozma","year":"2020","unstructured":"Kozma GT, Shimizu T, Ishida T, Szebeni J. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020;154\u2013155:163\u201375. https:\/\/doi.org\/10.1016\/j.addr.2020.07.024.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"1887_CR232","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1007\/s13346-024-01608-8","volume":"14","author":"AM L\u00f3pez-Estevez","year":"2024","unstructured":"L\u00f3pez-Estevez AM, Gref R, Alonso MJ. A journey through the history of PEGylated drug delivery nanocarriers. Drug Deliv Transl Res. 2024;14(8):2026\u201331. https:\/\/doi.org\/10.1007\/s13346-024-01608-8.","journal-title":"Drug Deliv Transl Res"},{"key":"1887_CR233","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev. 2014;71:2\u201314. https:\/\/doi.org\/10.1016\/j.addr.2013.08.008.","journal-title":"Adv Drug Deliv Rev"},{"issue":"50","key":"1887_CR234","doi-asserted-by":"publisher","first-page":"15343","DOI":"10.1021\/acs.langmuir.8b02946","volume":"34","author":"TD Clemons","year":"2018","unstructured":"Clemons TD, Singh R, Sorolla A, Chaudhari N, Hubbard A, Iyer KS. Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy. Langmuir. 2018;34(50):15343\u20139. https:\/\/doi.org\/10.1021\/acs.langmuir.8b02946.","journal-title":"Langmuir"},{"key":"1887_CR235","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.pneurobio.2019.101665","volume":"181","author":"KB Johnsen","year":"2019","unstructured":"Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T. Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol. 2019;181:101665. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101665.","journal-title":"Prog Neurobiol"},{"issue":"7","key":"1887_CR236","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/biology9070161","volume":"9","author":"S Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 S, et al. Development of an LDL receptor-targeted peptide susceptible to facilitate the brain access of diagnostic or therapeutic agents. Biology (Basel). 2020;9(7):161. https:\/\/doi.org\/10.3390\/biology9070161.","journal-title":"Biology (Basel)"},{"issue":"3","key":"1887_CR237","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","volume":"13","author":"B Gabold","year":"2023","unstructured":"Gabold B, et al. Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Deliv Transl Res. 2023;13(3):822\u201338. https:\/\/doi.org\/10.1007\/s13346-022-01245-z.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"1887_CR238","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","volume":"89","author":"YJY Zuchero","year":"2016","unstructured":"Zuchero YJY, et al. Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies. Neuron. 2016;89(1):70\u201382. https:\/\/doi.org\/10.1016\/j.neuron.2015.11.024.","journal-title":"Neuron"},{"issue":"5","key":"1887_CR239","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1471-4159.2010.06708.x","volume":"113","author":"S Ito","year":"2010","unstructured":"Ito S, Ueno T, Ohtsuki S, Terasaki T. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-\u03b2 peptide(1\u201340) in mouse: involvement of an LRP-1-independent pathway. J Neurochem. 2010;113(5):1356\u201363. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06708.x.","journal-title":"J Neurochem"},{"issue":"1","key":"1887_CR240","first-page":"19","volume":"85","author":"G-W Go","year":"2012","unstructured":"Go G-W, Mani A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J Biol Med. 2012;85(1):19\u201328.","journal-title":"Yale J Biol Med"},{"issue":"5","key":"1887_CR241","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1096\/fj.201600827R","volume":"31","author":"Y Molino","year":"2017","unstructured":"Molino Y, et al. Use of LDL receptor\u2014targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier. FASEB J. 2017;31(5):1807\u201327. https:\/\/doi.org\/10.1096\/fj.201600827R.","journal-title":"FASEB J"},{"issue":"18","key":"1887_CR242","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, et al. Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer\u2019s disease. ACS Nano. 2024;18(18):11753\u201368. https:\/\/doi.org\/10.1021\/acsnano.3c13150.","journal-title":"ACS Nano"},{"issue":"1","key":"1887_CR243","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/10717544.2018.1436099","volume":"25","author":"C Fornaguera","year":"2018","unstructured":"Fornaguera C, et al. Application of an assay cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas. Drug Deliv. 2018;25(1):472\u201383. https:\/\/doi.org\/10.1080\/10717544.2018.1436099.","journal-title":"Drug Deliv"},{"key":"1887_CR244","doi-asserted-by":"publisher","unstructured":"Tang M, Monani UR. Glut1 deficiency syndrome: new and emerging insights into a prototypical brain energy failure disorder. Neurosci Insights. 2021l;16. https:\/\/doi.org\/10.1177\/26331055211011507.","DOI":"10.1177\/26331055211011507"},{"issue":"2","key":"1887_CR245","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab. 2010;298(2):E141\u20135. https:\/\/doi.org\/10.1152\/ajpendo.00712.2009.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"1887_CR246","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/pharmaceutics14050987","volume":"14","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, et al. Current strategies to enhance delivery of drugs across the blood-brain barrier. Pharmaceutics. 2022;14(5):987. https:\/\/doi.org\/10.3390\/pharmaceutics14050987.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1887_CR247","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/s41467-019-12426-9","volume":"10","author":"A Abrahao","year":"2019","unstructured":"Abrahao A, et al. First-in-human trial of blood\u2013brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nat Commun. 2019;10(1):4373. https:\/\/doi.org\/10.1038\/s41467-019-12426-9.","journal-title":"Nat Commun"},{"key":"1887_CR248","doi-asserted-by":"publisher","unstructured":"Hashimoto Y, Campbell M. Tight junction modulation at the blood-brain barrier: current and future perspectives. Biochim Biophys Acta (BBA) \u2013 Biomembr. 2020;1862(9):183298. https:\/\/doi.org\/10.1016\/j.bbamem.2020.183298.","DOI":"10.1016\/j.bbamem.2020.183298"},{"issue":"1","key":"1887_CR249","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41598-020-57943-6","volume":"10","author":"T Lima","year":"2020","unstructured":"Lima T, Bernfur K, Vilanova M, Cedervall T. Understanding the lipid and protein corona formation on different sized polymeric nanoparticles. Sci Rep. 2020;10(1):1129. https:\/\/doi.org\/10.1038\/s41598-020-57943-6.","journal-title":"Sci Rep"},{"issue":"4","key":"1887_CR250","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/ntrev-2016-0098","volume":"6","author":"J Shannahan","year":"2017","unstructured":"Shannahan J. The biocorona: a challenge for the biomedical application of nanoparticles. Nanotechnol Rev. 2017;6(4):345\u201353. https:\/\/doi.org\/10.1515\/ntrev-2016-0098.","journal-title":"Nanotechnol Rev"},{"key":"1887_CR251","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.2147\/IJN.S254808","volume":"15","author":"SJ Park","year":"2020","unstructured":"Park SJ. Protein\u2013nanoparticle interaction: corona formation and conformational changes in proteins on nanoparticles. Int J Nanomedicine. 2020;15:5783\u2013802. https:\/\/doi.org\/10.2147\/IJN.S254808.","journal-title":"Int J Nanomedicine"},{"key":"1887_CR252","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.molimm.2022.08.002","volume":"150","author":"PF Zipfel","year":"2022","unstructured":"Zipfel PF, Skerka C. From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term \u2018complement.\u2019 Mol Immunol. 2022;150:90\u20138. https:\/\/doi.org\/10.1016\/j.molimm.2022.08.002.","journal-title":"Mol Immunol"},{"issue":"8","key":"1887_CR253","doi-asserted-by":"publisher","first-page":"17110","DOI":"10.1038\/nmicrobiol.2017.110","volume":"2","author":"J Blair","year":"2017","unstructured":"Blair J. Making magic bullets. Nat Microbiol. 2017;2(8):17110. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.110.","journal-title":"Nat Microbiol"},{"key":"1887_CR254","doi-asserted-by":"publisher","unstructured":"Welsh JA et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2). https:\/\/doi.org\/10.1002\/jev2.12404.","DOI":"10.1002\/jev2.12404"},{"key":"1887_CR255","unstructured":"Study details | therapeutic nanocatalysis to slow disease progression of amyotrophic lateral sclerosis (ALS) | ClinicalTrials.gov. [Online]. Available: https:\/\/clinicaltrials.gov\/study\/NCT04098406. Accessed 15 May 2025."},{"key":"1887_CR256","unstructured":"Study details | study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of NTLA-2001 in patients with hereditary transthyretin amyloidosis with Polyneuropathy (ATTRv-PN) and patients with transthyretin Amyloidosis-related cardiomyopathy (ATTR-CM) | ClinicalTrials.gov. [Online]. Available: https:\/\/clinicaltrials.gov\/study\/NCT04601051. Accessed 15 May 2025."},{"key":"1887_CR257","unstructured":"Study details | 31P-MRS imaging to assess the effects of CNM-Au8 on impaired neuronal redox state in Parkinson\u2019s disease | ClinicalTrials.gov. [Online]. Available: https:\/\/clinicaltrials.gov\/study\/NCT03815916. Accessed 15 May 2025."},{"issue":"6","key":"1887_CR258","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1039\/D2NA00800A","volume":"5","author":"M Naval\u00f3n-L\u00f3pez","year":"2023","unstructured":"Naval\u00f3n-L\u00f3pez M, Dols-Perez A, Grijalvo S, Fornaguera C, Borr\u00f3s S. Unravelling the role of individual components in pBAE\/polynucleotide polyplexes in the synthesis of tailored carriers for specific applications: on the road to rational formulations. Nanoscale Adv. 2023;5(6):1611\u201323. https:\/\/doi.org\/10.1039\/D2NA00800A.","journal-title":"Nanoscale Adv"},{"key":"1887_CR259","unstructured":"National Cancer Institute. Protocols and capabilities from the nanotechnology characterization lab. 2025. Available: https:\/\/www.cancer.gov\/nano\/research\/ncl\/protocols-capabilities. Accessed 15 May 2025."},{"key":"1887_CR260","unstructured":"Borros Gomez S, Rivero Monso FX, Cascante Cirera A. Polypeptides for blood brain barrier transport. 2014. (Patent No. WO 2014\/076655 A1)."},{"issue":"1","key":"1887_CR261","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12274-022-4849-6","volume":"16","author":"Y-F Wang","year":"2023","unstructured":"Wang Y-F, et al. The Yin and Yang of the protein corona on the delivery journey of nanoparticles. Nano Res. 2023;16(1):715\u201334. https:\/\/doi.org\/10.1007\/s12274-022-4849-6.","journal-title":"Nano Res"},{"issue":"6","key":"1887_CR262","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1039\/D2LC00799A","volume":"23","author":"G Bashiri","year":"2023","unstructured":"Bashiri G, Padilla MS, Swingle KL, Shepherd SJ, Mitchell MJ, Wang K. Nanoparticle protein corona: from structure and function to therapeutic targeting. Lab Chip. 2023;23(6):1432\u201366. https:\/\/doi.org\/10.1039\/D2LC00799A.","journal-title":"Lab Chip"},{"key":"1887_CR263","doi-asserted-by":"publisher","first-page":"114079","DOI":"10.1016\/j.addr.2021.114079","volume":"180","author":"D Shi","year":"2022","unstructured":"Shi D, et al. To PEGylate or not to PEGylate: Immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives. Adv Drug Deliv Rev. 2022;180:114079. https:\/\/doi.org\/10.1016\/j.addr.2021.114079.","journal-title":"Adv Drug Deliv Rev"},{"key":"1887_CR264","doi-asserted-by":"publisher","unstructured":"Fornaguera C et al. In vivo retargeting of poly(beta aminoester) (OM\u2010PBAE) nanoparticles is influenced by protein corona. Adv Healthc Mater. 2019;8(19). https:\/\/doi.org\/10.1002\/adhm.201900849.","DOI":"10.1002\/adhm.201900849"},{"key":"1887_CR265","doi-asserted-by":"publisher","unstructured":"Varea O, Guinovart JJ, Duran J. Malin restoration as proof of concept for gene therapy for Lafora disease. Brain Commun. 2022;4(4). https:\/\/doi.org\/10.1093\/braincomms\/fcac168.","DOI":"10.1093\/braincomms\/fcac168"},{"issue":"8","key":"1887_CR266","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/brain\/awab110","volume":"144","author":"J Duran","year":"2021","unstructured":"Duran J, et al. Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease. Brain. 2021;144(8):2349\u201360. https:\/\/doi.org\/10.1093\/brain\/awab110.","journal-title":"Brain"},{"key":"1887_CR267","doi-asserted-by":"publisher","first-page":"105173","DOI":"10.1016\/j.nbd.2020.105173","volume":"147","author":"O Varea","year":"2021","unstructured":"Varea O, Duran J, Aguilera M, Prats N, Guinovart JJ. Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity. Neurobiol Dis. 2021;147:105173. https:\/\/doi.org\/10.1016\/j.nbd.2020.105173.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1887_CR268","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","volume":"23","author":"J Duran","year":"2014","unstructured":"Duran J, Gruart A, Garcia-Rocha M, Delgado-Garcia JM, Guinovart JJ. Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. Hum Mol Genet. 2014;23(12):3147\u201356. https:\/\/doi.org\/10.1093\/hmg\/ddu024.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1887_CR269","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/cells12050722","volume":"12","author":"J Duran","year":"2023","unstructured":"Duran J. Role of astrocytes in the pathophysiology of Lafora disease and other glycogen storage disorders. Cells. 2023;12(5):722. https:\/\/doi.org\/10.3390\/cells12050722.","journal-title":"Cells"},{"issue":"5","key":"1887_CR270","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/jnc.15906","volume":"168","author":"MK Brewer","year":"2024","unstructured":"Brewer MK, et al. Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis. J Neurochem. 2024;168(5):744\u201359. https:\/\/doi.org\/10.1111\/jnc.15906.","journal-title":"J Neurochem"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01887-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:22:05Z","timestamp":1770304925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":270,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1887"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01887-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"19 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate does not apply in a review paper.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All data used in this review paper comes from published articles.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All authors gave their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests to be declared by any of the authors.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}